1
|
Mahamat‐Saleh Y, Rinaldi S, Kaaks R, Biessy C, Gonzalez‐Gil EM, Murphy N, Le Cornet C, Huerta JM, Sieri S, Tjønneland A, Mellemkjær L, Guevara M, Overvad K, Perez‐Cornago A, Tin Tin S, Padroni L, Simeon V, Masala G, May A, Monninkhof E, Christakoudi S, Heath AK, Tsilidis K, Agudo A, Schulze MB, Rothwell J, Cadeau C, Severi S, Weiderpass E, Gunter MJ, Dossus L. Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Med 2023; 12:12668-12682. [PMID: 37096432 PMCID: PMC10278526 DOI: 10.1002/cam4.5896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 03/06/2023] [Accepted: 03/23/2023] [Indexed: 04/26/2023] Open
Abstract
BACKGROUND Excess body fatness and hyperinsulinemia are both associated with an increased risk of postmenopausal breast cancer. However, whether women with high body fatness but normal insulin levels or those with normal body fatness and high levels of insulin are at elevated risk of breast cancer is not known. We investigated the associations of metabolically defined body size and shape phenotypes with the risk of postmenopausal breast cancer in a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. METHODS Concentrations of C-peptide-a marker for insulin secretion-were measured at inclusion prior to cancer diagnosis in serum from 610 incident postmenopausal breast cancer cases and 1130 matched controls. C-peptide concentrations among the control participants were used to define metabolically healthy (MH; in first tertile) and metabolically unhealthy (MU; >1st tertile) status. We created four metabolic health/body size phenotype categories by combining the metabolic health definitions with normal weight (NW; BMI < 25 kg/m2 , or WC < 80 cm, or WHR < 0.8) and overweight or obese (OW/OB; BMI ≥ 25 kg/m2 , or WC ≥ 80 cm, or WHR ≥ 0.8) status for each of the three anthropometric measures separately: (1) MHNW, (2) MHOW/OB, (3) MUNW, and (4) MUOW/OB. Conditional logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS Women classified as MUOW/OB were at higher risk of postmenopausal breast cancer compared to MHNW women considering BMI (OR = 1.58, 95% CI = 1.14-2.19) and WC (OR = 1.51, 95% CI = 1.09-2.08) cut points and there was also a suggestive increased risk for the WHR (OR = 1.29, 95% CI = 0.94-1.77) definition. Conversely, women with the MHOW/OB and MUNW were not at statistically significant elevated risk of postmenopausal breast cancer risk compared to MHNW women. CONCLUSION These findings suggest that being overweight or obese and metabolically unhealthy raises risk of postmenopausal breast cancer while overweight or obese women with normal insulin levels are not at higher risk. Additional research should consider the combined utility of anthropometric measures with metabolic parameters in predicting breast cancer risk.
Collapse
Affiliation(s)
| | - S. Rinaldi
- International Agency for Research on CancerLyonFrance
| | - R. Kaaks
- Division of Cancer EpidemiologyGerman Cancer Research Center (DFKZ)HeidelbergGermany
| | - C. Biessy
- International Agency for Research on CancerLyonFrance
| | | | - N. Murphy
- International Agency for Research on CancerLyonFrance
| | - C. Le Cornet
- Division of Cancer EpidemiologyGerman Cancer Research Center (DFKZ)HeidelbergGermany
| | - J. M. Huerta
- Department of EpidemiologyMurcia Regional Health CouncilMurciaSpain
- CIBER Epidemiología y Salud Pública (CIBERESP)MadridSpain
| | - S. Sieri
- Epidemiology and Prevention UnitFondazione IRCCS Istituto Nazionale dei Tumori20133MilanItaly
| | - A. Tjønneland
- Danish Cancer Society Research CenterCopenhagenDenmark
- Department of Public HealthUniversity of CopenhagenCopenhagenDenmark
| | - L. Mellemkjær
- Danish Cancer Society Research CenterCopenhagenDenmark
| | - M. Guevara
- Navarra Public Health Institute31003PamplonaSpain
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP)28029MadridSpain
- Navarra Institute for Health Research (IdiSNA)31008PamplonaSpain
| | - K. Overvad
- Department of Public Health, Section for EpidemiologyAarhus UniversityAarhusDenmark
| | - A. Perez‐Cornago
- Cancer Epidemiology UnitNuffield Department of Population HealthUniversity of OxfordOxfordUK
| | - S. Tin Tin
- Cancer Epidemiology UnitNuffield Department of Population HealthUniversity of OxfordOxfordUK
| | - L. Padroni
- Department of Clinical and Biological SciencesUniversity of TurinTurinItaly
| | - V. Simeon
- Dipartimento di Salute Mentale e Fisica e Medicina PreventivaUniversità degli Studi della Campania 'Luigi Vanvitelli'80121NaplesItaly
| | - G. Masala
- Institute for Cancer Research, Prevention and Clinical Network (ISPRO)FlorenceItaly
| | - A. May
- Julius Center for Health Sciences and Primary CareUniversity Medical Center UtrechtUtrecht UniversityUtrechtThe Netherlands
| | - E. Monninkhof
- Julius Center for Health Sciences and Primary CareUniversity Medical Center UtrechtUtrecht UniversityUtrechtThe Netherlands
| | - S. Christakoudi
- Department of Epidemiology and BiostatisticsSchool of Public Health, Imperial College LondonLondonUK
- Department of Inflammation BiologySchool of Immunology and Microbial SciencesKing's College LondonLondonUK
| | - A. K. Heath
- Department of Epidemiology and BiostatisticsSchool of Public Health, Imperial College LondonLondonUK
| | - K. Tsilidis
- Department of Epidemiology and BiostatisticsSchool of Public Health, Imperial College LondonLondonUK
| | - A. Agudo
- Unit of Nutrition and CancerCatalan Institute of Oncology – ICOL'Hospitalet de LlobregatSpain
- Nutrition and Cancer Group; Epidemiology, Public Health, Cancer Prevention and Palliative Care ProgramBellvitge Biomedical Research Institute – IDIBELLL'Hospitalet de LlobregatSpain
| | - M. B. Schulze
- Department of Molecular EpidemiologyGerman Institute of Human Nutrition Potsdam‐RehbrueckeNuthetalGermany
- Institute of Nutritional ScienceUniversity of PotsdamNuthetalGermany
| | - J. Rothwell
- Paris‐Saclay UniversityUVSQ, Inserm, Gustave Roussy, “Exposome and Heredity” team, CESPVillejuifFrance
| | - C. Cadeau
- Paris‐Saclay UniversityUVSQ, Inserm, Gustave Roussy, “Exposome and Heredity” team, CESPVillejuifFrance
| | - S. Severi
- Paris‐Saclay UniversityUVSQ, Inserm, Gustave Roussy, “Exposome and Heredity” team, CESPVillejuifFrance
| | - E. Weiderpass
- International Agency for Research on CancerLyonFrance
| | - M. J. Gunter
- International Agency for Research on CancerLyonFrance
| | - L. Dossus
- International Agency for Research on CancerLyonFrance
| |
Collapse
|
2
|
Vissers LET, Sluijs I, Burgess S, Forouhi NG, Freisling H, Imamura F, Nilsson TK, Renström F, Weiderpass E, Aleksandrova K, Dahm CC, Perez-Cornago A, Schulze MB, Tong TYN, Aune D, Bonet C, Boer JMA, Boeing H, Chirlaque MD, Conchi MI, Imaz L, Jäger S, Krogh V, Kyrø C, Masala G, Melander O, Overvad K, Panico S, Sánches MJ, Sonestedt E, Tjønneland A, Tzoulaki I, Verschuren WMM, Riboli E, Wareham NJ, Danesh J, Butterworth AS, van der Schouw YT. Milk intake and incident stroke and CHD in populations of European descent: a Mendelian randomisation study. Br J Nutr 2022; 128:1789-1797. [PMID: 34670632 PMCID: PMC9592953 DOI: 10.1017/s0007114521004244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Revised: 07/01/2021] [Accepted: 09/22/2021] [Indexed: 12/29/2022]
Abstract
Higher milk intake has been associated with a lower stroke risk, but not with risk of CHD. Residual confounding or reverse causation cannot be excluded. Therefore, we estimated the causal association of milk consumption with stroke and CHD risk through instrumental variable (IV) and gene-outcome analyses. IV analysis included 29 328 participants (4611 stroke; 9828 CHD) of the European Prospective Investigation into Cancer and Nutrition (EPIC)-CVD (eight European countries) and European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-NL) case-cohort studies. rs4988235, a lactase persistence (LP) SNP which enables digestion of lactose in adulthood was used as genetic instrument. Intake of milk was first regressed on rs4988235 in a linear regression model. Next, associations of genetically predicted milk consumption with stroke and CHD were estimated using Prentice-weighted Cox regression. Gene-outcome analysis included 777 024 participants (50 804 cases) from MEGASTROKE (including EPIC-CVD), UK Biobank and EPIC-NL for stroke, and 483 966 participants (61 612 cases) from CARDIoGRAM, UK Biobank, EPIC-CVD and EPIC-NL for CHD. In IV analyses, each additional LP allele was associated with a higher intake of milk in EPIC-CVD (β = 13·7 g/d; 95 % CI 8·4, 19·1) and EPIC-NL (36·8 g/d; 95 % CI 20·0, 53·5). Genetically predicted milk intake was not associated with stroke (HR per 25 g/d 1·05; 95 % CI 0·94, 1·16) or CHD (1·02; 95 % CI 0·96, 1·08). In gene-outcome analyses, there was no association of rs4988235 with risk of stroke (OR 1·02; 95 % CI 0·99, 1·05) or CHD (OR 0·99; 95 % CI 0·95, 1·03). Current Mendelian randomisation analysis does not provide evidence for a causal inverse relationship between milk consumption and stroke or CHD risk.
Collapse
Affiliation(s)
- L. E. T. Vissers
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
| | - I. Sluijs
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
| | - S. Burgess
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
| | - N. G. Forouhi
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - H. Freisling
- International Agency for Research on Cancer, Lyon, France
| | - F. Imamura
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - T. K. Nilsson
- Department of Medical Biosciences/Clinical Chemistry, Umeå University, Umeå, Sweden
| | - F. Renström
- Department of Biobank Research, Umeå University, Umeå, Sweden
- Division of Endocrinology and Diabetes, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
| | - E. Weiderpass
- International Agency for Research on Cancer, Lyon, France
| | - K. Aleksandrova
- Germany Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany
| | - C. C. Dahm
- Department of Public Health, Aarhus University, Aarhus, Denmark
| | - A. Perez-Cornago
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - M. B. Schulze
- German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
- German Center for Diabetes Research (DZD), Neuherberg, Germany
- Germany Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany
| | - T. Y. N. Tong
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - D. Aune
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
- Department of Nutrition, Bjørknes University College, Oslo, Norway
- Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway
| | - C. Bonet
- Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
| | - J. M. A. Boer
- National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - H. Boeing
- German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
| | - M. D. Chirlaque
- Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain
- CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - M. I. Conchi
- Navarra Public Health Institute – IdiSNA, Pamplona, Spain
- Research Network on Health Services in Chronic Diseases (REDISSEC), Pamplona, Spain
| | - L. Imaz
- Ministry of Health of the Basque Government, Public Health Division of Gipuzkoa, Donostia-San Sebastian, Spain
- Biodonostia Health Research Institute, Donostia-San Sebastian, Spain
| | - S. Jäger
- German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
- German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - V. Krogh
- Epidemiology and prevention Unit, Fondazione IRCCS Instituto Nazionale dei Tumori, Milano, Italy
| | - C. Kyrø
- Danish Cancer Society Research Center, Copenhagen, Denmark
| | - G. Masala
- Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network – ISPRO, Florence, Italy
| | - O. Melander
- Lund University, Department of Clinical Sciences, Malmö, Sweden
| | - K. Overvad
- Department of Public Health, Aarhus University, Aarhus, Denmark
- Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
| | - S. Panico
- Dipartemento di medicina clinica e chirurgia, Federico II University, Naples, Italy
| | - M. J. Sánches
- CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain
- Andalusian School of Public Health (EASP), Granada, Spain
- Instituto de Investigación Biosanitaria de Granada, Granada, Spain
- Universidad de Granada, Granada, Spain
| | - E. Sonestedt
- Lund University, Department of Clinical Sciences, Malmö, Sweden
| | - A. Tjønneland
- Danish Cancer Society Research Center, Copenhagen, Denmark
| | - I. Tzoulaki
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
| | - W. M. M. Verschuren
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
- National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - E. Riboli
- School of Public Health, Imperial College London, UK
| | - N. J. Wareham
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - J. Danesh
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - A. S. Butterworth
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
| | - Y. T. van der Schouw
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
| |
Collapse
|
3
|
Masala G, Bendinelli B, Della Bella C, Assedi M, Tapinassi S, Ermini I, Occhini D, Castaldo M, Saieva C, Caini S, D'Elios MM, Palli D. Inflammatory marker changes in a 24-month dietary and physical activity randomised intervention trial in postmenopausal women. Sci Rep 2020; 10:21845. [PMID: 33318523 PMCID: PMC7736293 DOI: 10.1038/s41598-020-78796-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Accepted: 11/19/2020] [Indexed: 12/22/2022] Open
Abstract
Chronic low-grade inflammation plays a role in the pathogenesis of several chronic diseases including cancer. Physical activity (PA) and diet have been supposed to modulate inflammatory markers. We evaluated the effects of a 24-month dietary and/or PA intervention on plasma levels of pro-inflammatory cytokines, a secondary analysis in the DAMA factorial trial. The 234 study participants (healthy postmenopausal women with high breast density, 50-69 years, non smokers, no hormone therapy) were randomised to four arms: (1) isocaloric dietary intervention mainly based on plant-foods; (2) moderate-intensity PA intervention with at least 1 h/week of supervised strenuous activity; (3) both interventions; (4) general recommendations on healthy dietary and PA patterns. Interleukins (IL)-1α, -1β, -6, tumor necrosis factor-α and C-reactive protein were measured at baseline and at the end of the intervention. Intention-to-treat-analyses were carried out using Tobit regression. Although all cytokines tended to increase over time, after 24 months women in the PA intervention (arms 2 + 3) showed lower levels of IL-1α (exp(β) = 0.66; p = 0.04) and IL-6 (exp(β) = 0.70; p = 0.01) in comparison with women in the control group (arms 1 + 4). No effects of the dietary intervention emerged. In healthy postmenopausal women with high breast density a moderate-intensity PA appears to slow the age-related increase of pro-inflammatory cytokines.
Collapse
Affiliation(s)
- G Masala
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy.
| | - B Bendinelli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| | - C Della Bella
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
| | - M Assedi
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| | - S Tapinassi
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
| | - I Ermini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| | - D Occhini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| | - M Castaldo
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| | - C Saieva
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| | - S Caini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| | - M M D'Elios
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
| | - D Palli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, Florence, Italy
| |
Collapse
|
4
|
Cordova R, Knaze V, Viallon V, Rust P, Schalkwijk CG, Weiderpass E, Wagner KH, Mayen-Chacon AL, Aglago EK, Dahm CC, Overvad K, Tjønneland A, Halkjær J, Mancini FR, Boutron-Ruault MC, Fagherazzi G, Katzke V, Kühn T, Schulze MB, Boeing H, Trichopoulou A, Karakatsani A, Thriskos P, Masala G, Krogh V, Panico S, Tumino R, Ricceri F, Spijkerman A, Boer J, Skeie G, Rylander C, Borch KB, Quirós JR, Agudo A, Redondo-Sánchez D, Amiano P, Gómez-Gómez JH, Barricarte A, Ramne S, Sonestedt E, Johansson I, Esberg A, Tong T, Aune D, Tsilidis KK, Gunter MJ, Jenab M, Freisling H. Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults. Eur J Nutr 2020; 59:2893-2904. [PMID: 31701336 DOI: 10.1007/s00394-019-02129-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Accepted: 10/23/2019] [Indexed: 12/17/2022]
Abstract
PURPOSE Advanced glycation end products (AGEs) can be formed in foods by the reaction of reducing sugars with proteins, and have been shown to induce insulin resistance and obesity in experimental studies. We examined the association between dietary AGEs intake and changes in body weight in adults over an average of 5 years of follow-up. METHODS A total of 255,170 participants aged 25-70 years were recruited in ten European countries (1992-2000) in the PANACEA study (Physical Activity, Nutrition, Alcohol, Cessation of smoking, Eating out of home in relation to Anthropometry), a sub-cohort of the EPIC (European Prospective Investigation into Cancer and Nutrition). Body weight was measured at recruitment and self-reported between 2 and 11 years later depending on the study center. A reference database for AGEs was used containing UPLC-MS/MS-measured Nε-(carboxymethyl)-lysine (CML), Nε-(1-carboxyethyl)-lysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) in 200 common European foods. This reference database was matched to foods and decomposed recipes obtained from country-specific validated dietary questionnaires in EPIC and intake levels of CEL, CML, and MG-H1 were estimated. Associations between dietary AGEs intake and body weight change were estimated separately for each of the three AGEs using multilevel mixed linear regression models with center as random effect and dietary AGEs intake and relevant confounders as fixed effects. RESULTS A one-SD increment in CEL intake was associated with 0.111 kg (95% CI 0.087-0.135) additional weight gain over 5 years. The corresponding additional weight gain for CML and MG-H1 was 0.065 kg (0.041-0.089) and 0.034 kg (0.012, 0.057), respectively. The top six food groups contributing to AGEs intake, with varying proportions across the AGEs, were cereals/cereal products, meat/processed meat, cakes/biscuits, dairy, sugar and confectionary, and fish/shellfish. CONCLUSION In this study of European adults, higher intakes of AGEs were associated with marginally greater weight gain over an average of 5 years of follow-up.
Collapse
Affiliation(s)
- R Cordova
- Department of Nutritional Sciences, University of Vienna, Vienna, Austria
| | - V Knaze
- Section of Early Detection and Prevention, International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - V Viallon
- Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - P Rust
- Department of Nutritional Sciences, University of Vienna, Vienna, Austria
| | - C G Schalkwijk
- Department of Internal Medicine, Laboratory of Metabolism and Vascular Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
| | - E Weiderpass
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - K-H Wagner
- Department of Nutritional Sciences, University of Vienna, Vienna, Austria
| | - A-L Mayen-Chacon
- Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - E K Aglago
- Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - C C Dahm
- Department of Public Health, Aarhus University, Aarhus, Denmark
| | - K Overvad
- Department of Public Health, Aarhus University, Aarhus, Denmark
- Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
| | - A Tjønneland
- Danish Cancer Society Research Center Copenhagen, Copenhagen, Denmark
- Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - J Halkjær
- Danish Cancer Society Research Center Copenhagen, Copenhagen, Denmark
| | - F R Mancini
- CESP, Fac. de médecine, Univ. Paris-Sud, Fac. de médecine-UVSQ-INSERM, Université Paris-Saclay, Villejuif, France
- Institut Gustave Roussy, Villejuif, France
| | - M-C Boutron-Ruault
- CESP, Fac. de médecine, Univ. Paris-Sud, Fac. de médecine-UVSQ-INSERM, Université Paris-Saclay, Villejuif, France
- Institut Gustave Roussy, Villejuif, France
| | - G Fagherazzi
- CESP, Fac. de médecine, Univ. Paris-Sud, Fac. de médecine-UVSQ-INSERM, Université Paris-Saclay, Villejuif, France
- Institut Gustave Roussy, Villejuif, France
| | - V Katzke
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - T Kühn
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - M B Schulze
- Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
- Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany
| | - H Boeing
- Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
| | | | - A Karakatsani
- Hellenic Health Foundation, Athens, Greece
- 2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, ATTIKON University Hospital, Haidari, Greece
| | - P Thriskos
- Hellenic Health Foundation, Athens, Greece
| | - G Masala
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy
| | - V Krogh
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - S Panico
- Dipartimento di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy
| | - R Tumino
- Cancer Registry and Histopathology Unit, Azienda Sanitaria Provinciale (ASP) Ragusa, Ragusa, Italy
| | - F Ricceri
- Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
- Unit of Epidemiology, Regional Health Service ASL TO3, Turin, TO, Italy
| | - A Spijkerman
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - J Boer
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - G Skeie
- Department of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway
| | - C Rylander
- Department of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway
| | - K B Borch
- Department of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway
| | - J R Quirós
- Public Health Directorate, Asturias, Spain
| | - A Agudo
- Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - D Redondo-Sánchez
- Andalusian School of Public Health. Biomedical Research Institute ibs.GRANADA, University of Granada, Granada, Spain
- CIBER of Epidemiology and Public Health, Madrid, Spain
| | - P Amiano
- CIBER of Epidemiology and Public Health, Madrid, Spain
- Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain
| | - J-H Gómez-Gómez
- Department of Epidemiology and Murcia Regional Health Council, Universidad de Murcia, Murcia, Spain
| | - A Barricarte
- CIBER of Epidemiology and Public Health, Madrid, Spain
- Navarra Public Health Institute, Pamplona, Spain
- Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
| | - S Ramne
- Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
| | - E Sonestedt
- Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
| | - I Johansson
- Department of Odontology, Umeå University, Umeå, Sweden
| | - A Esberg
- Department of Odontology, Umeå University, Umeå, Sweden
| | - T Tong
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - D Aune
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
| | - K K Tsilidis
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
- Department of Hygiene and Epidemiology, University of Ioannina School of Medicine University Campus Ioannina, Ioannina, Greece
| | - M J Gunter
- Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - M Jenab
- Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - Heinz Freisling
- International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, CEDEX 08, 69372, Lyon, France.
| |
Collapse
|
5
|
Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Van Gils CH, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ. Abstract P1-08-01: Withdrawn. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p1-08-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Citation Format: Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami H-O, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault M-C, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh W-P, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Van Gils CH, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan J-M, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P1-08-01.
Collapse
Affiliation(s)
- MJ Schoemaker
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - HB Nichols
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - LB Wright
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - MN Brook
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - ME Jones
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - KM O'Brien
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - H-O Adami
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - L Baglietto
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - L Bernstein
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - KA Bertrand
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - M-C Boutron-Ruault
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - Y Chen
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - AE Connor
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - M Dorronsoro
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - L Dossus
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - AH Eliassen
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - GG Giles
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - IT Gram
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - SE Hankinson
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - R Kaaks
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - TJ Key
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - VA Kirsh
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - CM Kitahara
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - W-P Koh
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - SC Larsson
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - MS Linet
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - H Ma
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - G Masala
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - MA Merritt
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - RL Milne
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - K Overvad
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - K Ozasa
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - JR Palmer
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - E Riboli
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - TE Rohan
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - A Sadakane
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - M Sund
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - RM Tamimi
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - A Trichopoulou
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - G Ursin
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - CH Van Gils
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - K Visvanathan
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - E Weiderpass
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - WC Willett
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - A Wolk
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - J-M Yuan
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - A Zeleniuch-Jacquotte
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - DP Sandler
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| | - AJ Swerdlow
- The Institute of Cancer Research, London, United Kingdom; University of North Carolina Gillings School of Global Public Health, Chapel Hill; National Institute of Environmental Health Sciences, Durham; Harvard T.H. Chan School of Public Health, Boston; University of Pisa, Pisa, Italy; Beckman Research Institute of City of Hope, Duarte; Slone Epidemiology Center at Boston University, Boston; CESP Center for Research in Epidemiology and Population Health, Paris, France; New York University School of Medicine, New York; Johns Hopkins Bloomberg School of Public Health, Baltimore; Public Health Direction and Biodonostia Research Institute and Ciberesp, San Sebastian, Spain; International Agency for Research on Cancer, Lyon, France; The University of Melbourne, Melbourne, Australia; University of Tromsø (UiT) The Arctic University of Norway, Tromsø, Norway; University of Massachusetts, Amherst; German Cancer Research Center (DKFZ), Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of To
| |
Collapse
|
6
|
Gandini S, Lazzeroni M, Peccatori FA, Bendinelli B, Saieva C, Palli D, Masala G, Caini S. The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis. Crit Rev Oncol Hematol 2019; 134:72-81. [PMID: 30771877 DOI: 10.1016/j.critrevonc.2018.12.009] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2018] [Revised: 12/29/2018] [Accepted: 12/30/2018] [Indexed: 01/23/2023] Open
Abstract
We conducted a meta-analysis of studies reporting on the risk of extra-ovarian malignancies among women with endometriosis. Summary relative risk (SRR) and 95% confidence intervals (CI) were calculated through random effect models. We explored causes of between-studies heterogeneity and assessed the presence of publication bias. We included 32 studies published between 1989 and 2018. We found an increased risk of endometrial (SRR 1.38, 95%CI 1.10-1.74) and thyroid cancer (SRR 1.38, 95%CI 1.17-1.63), and inverse association with cervical cancer (SRR 0.78, 95%CI 0.60-0.95). No association emerged for breast cancer (SRR 1.04, 95%CI 0.99-1.09) and melanoma (SRR 1.31, 95%CI 0.86-1.96). Between-study heterogeneity was large for breast and endometrial cancer and melanoma. Associations were generally stronger in case-control, cross-sectional, and cohort studies with internal control group, compared to cohort studies with external control group. No indication for publication bias was found. Our conclusions need to be confirmed in properly designed cohort studies with clinical confirmation of endometriosis.
Collapse
Affiliation(s)
- S Gandini
- Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy
| | - M Lazzeroni
- Division of Cancer Prevention and Genetics, European Institute of Oncology IRCCS, Milan, Italy
| | - F A Peccatori
- Division of Gynecology Oncology, European Institute of Oncology IRCCS, Milan, Italy
| | - B Bendinelli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
| | - C Saieva
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
| | - D Palli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
| | - G Masala
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
| | - S Caini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
| |
Collapse
|
7
|
Millarini V, Caini S, Allamani A, Ermini I, Querci A, Masala G, Fabbri S. Prevalence and co-occurrence of unhealthy lifestyle habits and behaviours among secondary school students in Tuscany, central Italy. Public Health 2018; 166:89-98. [PMID: 30472313 DOI: 10.1016/j.puhe.2018.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Revised: 09/28/2018] [Accepted: 10/04/2018] [Indexed: 11/28/2022]
Abstract
OBJECTIVES Unhealthy habits acquired during adolescence may persist in adulthood and eventually increase the risk of chronic illnesses. STUDY DESIGN We reported on a survey conducted in 2013-2015 among secondary school students in Tuscany, central Italy. METHODS We compared the prevalence of self-reported lifestyle characteristics and overweight/obesity between genders and age groups (14-16 vs 17-21 years). We partitioned each gender- and age-specific stratum into groups based on cigarette smoking and engagement in sport activities, and compared the prevalence of other unhealthy lifestyles across groups using Poisson regression. RESULTS Overall, 2167 students (53.3% males, mean age 16.8 years) were included. Males were more frequently overweight/obese than females. Cigarette smoking increased with age and did not differ by gender. Males were more likely to engage in sport activities, drink alcoholic beverages and adopt other unhealthy lifestyle habits, whereas females reported a more frequent use of painkillers. Cigarette smoking was the single lifestyle characteristic most consistently associated with other unhealthy habits. CONCLUSIONS The prevalence and patterns of co-occurrence of unhealthy lifestyle habits varied by gender and age group among secondary school students in Italy. Our findings should be taken into account when planning public health initiatives aiming to combat obesity and tackle unhealthy lifestyles among secondary school students in Italy.
Collapse
Affiliation(s)
- V Millarini
- Cancer Research "Attilia Pofferi" Foundation, Pistoia, 51100, Italy.
| | - S Caini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, 50139, Italy.
| | - A Allamani
- Former Head of the Alcohol Centre, Health Agency of Tuscany Region, Florence, 50139, Italy.
| | - I Ermini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, 50139, Italy.
| | - A Querci
- Cancer Research "Attilia Pofferi" Foundation, Pistoia, 51100, Italy.
| | - G Masala
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, 50139, Italy.
| | - S Fabbri
- Cancer Research "Attilia Pofferi" Foundation, Pistoia, 51100, Italy.
| |
Collapse
|
8
|
Bendinelli B, Masala G, Bruno RM, Caini S, Saieva C, Boninsegni A, Ungar A, Ghiadoni L, Palli D. A priori dietary patterns and blood pressure in the EPIC Florence cohort: a cross-sectional study. Eur J Nutr 2018; 58:455-466. [PMID: 29951936 DOI: 10.1007/s00394-018-1758-2] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Accepted: 06/20/2018] [Indexed: 12/18/2022]
Abstract
PURPOSE Several foods and nutrients have been independently associated with systolic (SBP) and diastolic (DBP) blood pressure values. This study aimed to evaluate the effects of combined dietary habits on SBP and DBP values in a large cohort of healthy adults, with a cross-sectional design. Adherence of participants to four a priori dietary patterns was considered: the Healthy Eating Index 2010 (HEI-2010); the Dietary Approaches to Stop Hypertension (DASH); the Greek Mediterranean Diet Score (MDS); and the Italian Mediterranean Index (IMI). METHODS Overall, 13,597 volunteers (35-64 years) were enrolled in 1993-1998 in the EPIC-Florence cohort. Information on dietary habits, anthropometry, smoking status, education, physical activity habits, previous diagnosis of hypertension and SBP and DBP measurements were collected at baseline. Multivariate regression models were performed on 10,163 individuals (7551 women) after excluding subjects with prevalent hypertension. RESULTS IMI, DASH and HEI-2010 were significantly and inversely associated with SBP and DBP values in the total population. The strongest association emerged between IMI and SBP (β - 1.80 excellent adherence vs low adherence, 95% CI - 2.99; - 0.61, p trend 0.001) and DBP (β - 1.12, 95% CI - 1.869; - 0.39, p trend 0.001) values. In sub-group analyses, an inverse association also emerged between IMI and SBP and DBP values among females and between DASH and DBP among males. MDS was not associated with SBP or DBP. CONCLUSION Overall, this study, carried out in a large cohort of healthy adults from Tuscany (Central Italy), showed inverse significant associations between specific a priori dietary patterns, identifying general models of health-conscious diet, and blood pressure values.
Collapse
Affiliation(s)
- B Bendinelli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for cancer research, prevention and clinical network, ISPRO, Via delle Oblate 4, 50141, Florence, Italy
| | - G Masala
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for cancer research, prevention and clinical network, ISPRO, Via delle Oblate 4, 50141, Florence, Italy.
| | - R M Bruno
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - S Caini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for cancer research, prevention and clinical network, ISPRO, Via delle Oblate 4, 50141, Florence, Italy
| | - C Saieva
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for cancer research, prevention and clinical network, ISPRO, Via delle Oblate 4, 50141, Florence, Italy
| | - A Boninsegni
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for cancer research, prevention and clinical network, ISPRO, Via delle Oblate 4, 50141, Florence, Italy
| | - A Ungar
- Division of Geriatric Cardiology and Medicine, University of Florence, Florence, Italy.,Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | - L Ghiadoni
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - D Palli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for cancer research, prevention and clinical network, ISPRO, Via delle Oblate 4, 50141, Florence, Italy
| |
Collapse
|
9
|
Chajès V, Assi N, Biessy C, Ferrari P, Rinaldi S, Slimani N, Lenoir GM, Baglietto L, His M, Boutron-Ruault MC, Trichopoulou A, Lagiou P, Katsoulis M, Kaaks R, Kühn T, Panico S, Pala V, Masala G, Bueno-de-Mesquita HB, Peeters PH, van Gils C, Hjartåker A, Standahl Olsen K, Borgund Barnung R, Barricarte A, Redondo-Sanchez D, Menéndez V, Amiano P, Wennberg M, Key T, Khaw KT, Merritt MA, Riboli E, Gunter MJ, Romieu I. A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study. Ann Oncol 2017; 28:2836-2842. [PMID: 28950350 DOI: 10.1093/annonc/mdx482] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/08/2023] Open
Abstract
BACKGROUND Intakes of specific fatty acids have been postulated to impact breast cancer risk but epidemiological data based on dietary questionnaires remain conflicting. MATERIALS AND METHODS We assessed the association between plasma phospholipid fatty acids and breast cancer risk in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition study. Sixty fatty acids were measured by gas chromatography in pre-diagnostic plasma phospholipids from 2982 incident breast cancer cases matched to 2982 controls. Conditional logistic regression models were used to estimate relative risk of breast cancer by fatty acid level. The false discovery rate (q values) was computed to control for multiple comparisons. Subgroup analyses were carried out by estrogen receptor (ER) and progesterone receptor expression in the tumours. RESULTS A high level of palmitoleic acid [odds ratio (OR) for the highest quartile compared with the lowest OR (Q4-Q1) 1.37; 95% confidence interval (CI), 1.14-1.64; P for trend = 0.0001, q value = 0.004] as well as a high desaturation index (DI16) (16:1n-7/16:0) [OR (Q4-Q1), 1.28; 95% C, 1.07-1.54; P for trend = 0.002, q value = 0.037], as biomarkers of de novo lipogenesis, were significantly associated with increased risk of breast cancer. Levels of industrial trans-fatty acids were positively associated with ER-negative tumours [OR for the highest tertile compared with the lowest (T3-T1)=2.01; 95% CI, 1.03-3.90; P for trend = 0.047], whereas no association was found for ER-positive tumours (P-heterogeneity =0.01). No significant association was found between n-3 polyunsaturated fatty acids and breast cancer risk, overall or by hormonal receptor. CONCLUSION These findings suggest that increased de novo lipogenesis, acting through increased synthesis of palmitoleic acid, could be a relevant metabolic pathway for breast tumourigenesis. Dietary trans-fatty acids derived from industrial processes may specifically increase ER-negative breast cancer risk.
Collapse
Affiliation(s)
- V Chajès
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon.
| | - N Assi
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon
| | - C Biessy
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon
| | - P Ferrari
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon
| | - S Rinaldi
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon
| | - N Slimani
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon
| | | | - L Baglietto
- Institut Gustave Roussy, Villejuif; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France
| | - M His
- Institut Gustave Roussy, Villejuif; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France
| | - M C Boutron-Ruault
- Institut Gustave Roussy, Villejuif; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France
| | - A Trichopoulou
- Hellenic Health Foundation, Athens; WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece
| | - P Lagiou
- Hellenic Health Foundation, Athens; WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece; Department of Epidemiology, Harvard School of Public Health, Boston, USA
| | | | - R Kaaks
- The German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - T Kühn
- The German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - S Panico
- Dipartimento Di Medicina Clinica E Chirurgia, Federico II University, Naples
| | - V Pala
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - G Masala
- Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy
| | - H B Bueno-de-Mesquita
- Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - P H Peeters
- Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - C van Gils
- Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - A Hjartåker
- Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo
| | - K Standahl Olsen
- Department of Community Medicine, University of Tromsø-UiT-The Artic University of Norway, Tromsø, Norway
| | - R Borgund Barnung
- Department of Community Medicine, University of Tromsø-UiT-The Artic University of Norway, Tromsø, Norway
| | - A Barricarte
- Navarra Public Health Institute, Pamplona; Navarra Institute for Health Research (IdiSNA), Pamplona; CIBER Epidemiology and Public Health CIBERESP, Madrid
| | - D Redondo-Sanchez
- CIBER Epidemiology and Public Health CIBERESP, Madrid; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.Granada, Hospitales Universitarios de Granada, Granada; Universidad de Granada, Granada
| | | | - P Amiano
- CIBER Epidemiology and Public Health CIBERESP, Madrid; Public Health Division of Gipuzkoa, Health Department, Basque Region, San Sebastian, Spain
| | - M Wennberg
- Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden
| | - T Key
- The Cancer Epidemiology Unit, University of Oxford, Oxford
| | - K T Khaw
- University of Cambridge School of Clinical Medicine, Cambridge, UK
| | - M A Merritt
- Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK
| | - E Riboli
- Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK
| | - M J Gunter
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon
| | - I Romieu
- Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon
| |
Collapse
|
10
|
Sieri S, Agnoli C, Pala V, Grioni S, Brighenti F, Pellegrini N, Masala G, Palli D, Mattiello A, Panico S, Ricceri F, Fasanelli F, Frasca G, Tumino R, Krogh V. Dietary glycemic index, glycemic load, and cancer risk: results from the EPIC-Italy study. Sci Rep 2017; 7:9757. [PMID: 28851931 PMCID: PMC5575161 DOI: 10.1038/s41598-017-09498-2] [Citation(s) in RCA: 55] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2017] [Accepted: 07/27/2017] [Indexed: 12/21/2022] Open
Abstract
Factors linked to glucose metabolism are involved in the etiology of several cancers. High glycemic index (GI) or high glycemic load (GL) diets, which chronically raise postprandial blood glucose, may increase cancer risk by affecting insulin-like growth factor. We prospectively investigated cancer risk and dietary GI/GL in the EPIC-Italy cohort. After a median 14.9 years, 5112 incident cancers and 2460 deaths were identified among 45,148 recruited adults. High GI was associated with increased risk of colon and bladder cancer. High GL was associated with: increased risk of colon cancer; increased risk of diabetes-related cancers; and decreased risk of rectal cancer. High intake of carbohydrate from high GI foods was significantly associated with increased risk of colon and diabetes-related cancers, but decreased risk of stomach cancer; whereas high intake of carbohydrates from low GI foods was associated with reduced colon cancer risk. In a Mediterranean population with high and varied carbohydrate intake, carbohydrates that strongly raise postprandial blood glucose may increase colon and bladder cancer risk, while the quantity of carbohydrate consumed may be involved in diabetes-related cancers. Further studies are needed to confirm the opposing effects of high dietary GL on risks of colon and rectal cancers.
Collapse
Affiliation(s)
- S Sieri
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - C Agnoli
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - V Pala
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - S Grioni
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - F Brighenti
- Department of Public Health, University of Parma, Parma, Italy
| | - N Pellegrini
- Department of Public Health, University of Parma, Parma, Italy
| | - G Masala
- Molecular and Nutritional Epidemiology Unit, ISPO-Cancer Research and Prevention Institute, Florence, Italy
| | - D Palli
- Molecular and Nutritional Epidemiology Unit, ISPO-Cancer Research and Prevention Institute, Florence, Italy
| | - A Mattiello
- Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
| | - S Panico
- Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
| | - F Ricceri
- Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.,Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Turin, Italy
| | - F Fasanelli
- Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy
| | - G Frasca
- Cancer Registry, Department of Medical Prevention, ASP Ragusa, Italy
| | - R Tumino
- Cancer Registry, Department of Medical Prevention, ASP Ragusa, Italy
| | - V Krogh
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
| |
Collapse
|
11
|
Masala G, Bendinelli B, Occhini D, Bruno RM, Caini S, Saieva C, Ungar A, Ghiadoni L, Palli D. Physical activity and blood pressure in 10,000 Mediterranean adults: The EPIC-Florence cohort. Nutr Metab Cardiovasc Dis 2017; 27:670-678. [PMID: 28755806 DOI: 10.1016/j.numecd.2017.06.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2017] [Revised: 06/08/2017] [Accepted: 06/08/2017] [Indexed: 10/19/2022]
Abstract
BACKGROUND AND AIMS The relevant role of physical activity (PA) in cardiovascular risk prevention is widely agreed. We aimed to evaluate, in a large Mediterranean population, the influence of PA on systolic (SBP) and diastolic blood pressure (DBP), taking into account individual characteristics and lifestyle habits. METHODS AND RESULTS In the Florence section of the European Prospective Investigation into Cancer and Nutrition 10,163 individuals, 35-64 years, without a previous diagnosis of hypertension were recruited. Information on occupational and leisure-time PA and blood pressure were collected at recruitment, together with data on lifestyle, dietary habits and anthropometry. Multivariate regression models were applied to evaluate the effect of total, occupational and leisure-time PA on SBP and DBP. Mean values of SBP and DBP in the study subjects were 124.4 (SD 15.6) and 79.7 mmHg (SD 9.4), respectively. Overall, a total PA index and an index including cycling, fitness and occupational PA (Cambridge index) were inversely associated with DBP (beta -0.87, p-value 0.02 actives vs inactives, p for trend 0.02 and beta -0.84, p value 0.003 actives vs inactives, p for trend 0.002, respectively), while SBP was associated only with the latter index (beta -1.14, p-value 0.01 actives vs inactives, p for trend 0.006). An inverse association emerged between manual/heavy manual occupation and DBP (p 0.02, ref sedentary/standing occupation) and between increasing cycling activity and SBP (p for trend 0.04). CONCLUSIONS In this large cohort of Mediterranean adults without a diagnosis of hypertension we confirm the role of overall PA in modulating SBP and DBP values. Cycling and manual occupations were associated with lower DBP values.
Collapse
Affiliation(s)
- G Masala
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy
| | - B Bendinelli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy
| | - D Occhini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy
| | - R M Bruno
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - S Caini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy
| | - C Saieva
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy
| | - A Ungar
- Division of Geriatric Cardiology and Medicine, University of Florence, Florence, Italy; Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | - L Ghiadoni
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - D Palli
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.
| |
Collapse
|
12
|
Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SSM, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR. Erratum: No association of alcohol use and the risk of ulcerative colitis or Crohn’s disease: data from a European Prospective cohort study (EPIC). Eur J Clin Nutr 2017; 71:566. [DOI: 10.1038/ejcn.2017.16] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
13
|
Racine A, Carbonnel F, Chan SSM, Hart AR, Bueno-de-Mesquita HB, Oldenburg B, van Schaik FDM, Tjønneland A, Olsen A, Dahm CC, Key T, Luben R, Khaw KT, Riboli E, Grip O, Lindgren S, Hallmans G, Karling P, Clavel-Chapelon F, Bergman MM, Boeing H, Kaaks R, Katzke VA, Palli D, Masala G, Jantchou P, Boutron-Ruault MC. Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study. Inflamm Bowel Dis 2016; 22:345-54. [PMID: 26717318 DOI: 10.1097/mib.0000000000000638] [Citation(s) in RCA: 165] [Impact Index Per Article: 20.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND Specific nutrients or foods have been inconsistently associated with ulcerative colitis (UC) or Crohn's disease (CD) risks. Thus, we investigated associations between diet as a whole, as dietary patterns, and UC and CD risks. METHODS Within the prospective EPIC (European Prospective Investigation into Cancer) study, we set up a nested matched case-control study among 366,351 participants with inflammatory bowel disease data, including 256 incident cases of UC and 117 of CD, and 4 matched controls per case. Dietary intake was recorded at baseline from validated food frequency questionnaires. Incidence rate ratios of developing UC and CD were calculated for quintiles of the Mediterranean diet score and a posteriori dietary patterns produced by factor analysis. RESULTS No dietary pattern was associated with either UC or CD risks. However, when excluding cases occurring within the first 2 years after dietary assessment, there was a positive association between a "high sugar and soft drinks" pattern and UC risk (incidence rate ratios for the fifth versus first quintile, 1.68 [1.00-2.82]; Ptrend = 0.02). When considering the foods most associated with the pattern, high consumers of sugar and soft drinks were at higher UC risk only if they had low vegetables intakes. CONCLUSIONS A diet imbalance with high consumption of sugar and soft drinks and low consumption of vegetables was associated with UC risk. Further studies are needed to investigate whether microbiota alterations or other mechanisms mediate this association.
Collapse
Affiliation(s)
- Antoine Racine
- 1INSERM, Centre for Research in Epidemiology and Population, Health, UMR1018, Institut Gustave Roussy, Université Paris Sud, Villejuif, France; 2Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Le Kremlin Bicêtre, France; 3Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, United Kingdom; 4Department of Gastroenterology, Norfolk and Norwich University Hospital NHS Trust, Norwich, United Kingdom; 5Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 6Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands; 7Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom; 8Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 9Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 10Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 11Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 12Strangeways Research Laboratory, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom; 13Division of Epidemiology, Imperial College London, London, United Kingdom; 14Department of Gastroenterology and Hepatology, University Hospital Malmö, Malmö, Sweden; 15Department of Public Health and Clinical Medicine, Nutritional Research, Umea University, Umea, Sweden; 16Department of Public Health and Clinical Medicine, GI unit, Umea University, Umea, Sweden; 17Department of Epidemiology, German Institute of Human Nutrition, Potsdam, Germany; 18Division of Clinical Epidemiology, DKFZ-German Cancer Research Centre Heidelberg, Heidelberg, Germany; 19Molecular and Nutritional Epidemio
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Polo MF, Mastrandrea S, Santoru L, Arcadu A, Masala G, Marras V, Bagella G, Sechi MM, Tanda F, Pirina P. Pulmonary inflammatory pseudotumor due to Coxiella burnetii. Case report and literature review. Microbes Infect 2015; 17:795-8. [PMID: 26342254 DOI: 10.1016/j.micinf.2015.08.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2015] [Revised: 08/24/2015] [Accepted: 08/25/2015] [Indexed: 11/17/2022]
Abstract
A 58-year-old man was admitted because of respiratory failure, episodic fever with chilling, cough, malaise, fatigue, myalgia and weight loss lasting for at least one month. Chest x-rays and CT scan of the chest showed bilateral pulmonary consolidations in upper lobes, the left lower lobe, and mediastinal lymphadenopathy. Bronchoscopy with cytology was unremarkable. A needle CT-guided lung biopsy documented an inflammatory pseudotumor, lymphoplasmacytic type. Serology showed high titer antibodies to phase II Coxiella burnetii infection. Therapy with doxycycline and hydroxychloroquine for three months led to a complete resolution of symptoms and radiological findings, and a marked decrease in titers to Q fever.
Collapse
Affiliation(s)
- M F Polo
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
| | - S Mastrandrea
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - L Santoru
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - A Arcadu
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - G Masala
- Experimental Zooprophylactic Institute of Sardinia, Sassari, Italy
| | - V Marras
- Department of Biomedical Sciences, Institute of Pathology, University of Sassari, Sassari, Italy
| | - G Bagella
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - M M Sechi
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - F Tanda
- Department of Biomedical Sciences, Institute of Pathology, University of Sassari, Sassari, Italy
| | - P Pirina
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| |
Collapse
|
15
|
Brand JS, Onland-Moret NC, Eijkemans MJC, Tjønneland A, Roswall N, Overvad K, Fagherazzi G, Clavel-Chapelon F, Dossus L, Lukanova A, Grote V, Bergmann MM, Boeing H, Trichopoulou A, Tzivoglou M, Trichopoulos D, Grioni S, Mattiello A, Masala G, Tumino R, Vineis P, Bueno-de-Mesquita HB, Weiderpass E, Redondo ML, Sánchez MJ, Castaño JMH, Arriola L, Ardanaz E, Duell EJ, Rolandsson O, Franks PW, Butt S, Nilsson P, Khaw KT, Wareham N, Travis R, Romieu I, Gunter MJ, Riboli E, van der Schouw YT. Diabetes and onset of natural menopause: results from the European Prospective Investigation into Cancer and Nutrition. Hum Reprod 2015; 30:1491-8. [PMID: 25779698 PMCID: PMC6284789 DOI: 10.1093/humrep/dev054] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2014] [Accepted: 12/05/2014] [Indexed: 01/10/2023] Open
Abstract
STUDY QUESTION Do women who have diabetes before menopause have their menopause at an earlier age compared with women without diabetes? SUMMARY ANSWER Although there was no overall association between diabetes and age at menopause, our study suggests that early-onset diabetes may accelerate menopause. WHAT IS KNOWN ALREADY Today, more women of childbearing age are being diagnosed with diabetes, but little is known about the impact of diabetes on reproductive health. STUDY DESIGN, SIZE, DURATION We investigated the impact of diabetes on age at natural menopause (ANM) in 258 898 women from the European Prospective Investigation into Cancer and Nutrition (EPIC), enrolled between 1992 and 2000. PARTICIPANTS/MATERIALS, SETTING, METHODS Determinant and outcome information was obtained through questionnaires. Time-dependent Cox regression analyses were used to estimate the associations of diabetes and age at diabetes diagnosis with ANM, stratified by center and adjusted for age, smoking, reproductive and diabetes risk factors and with age from birth to menopause or censoring as the underlying time scale. MAIN RESULTS AND THE ROLE OF CHANCE Overall, no association between diabetes and ANM was found (hazard ratio (HR) = 0.94; 95% confidence interval (CI) 0.89-1.01). However, women with diabetes before the age of 20 years had an earlier menopause (10-20 years: HR = 1.43; 95% CI 1.02-2.01, <10 years: HR = 1.59; 95% CI 1.03-2.43) compared with non-diabetic women, whereas women with diabetes at age 50 years and older had a later menopause (HR = 0.81; 95% CI 0.70-0.95). None of the other age groups were associated with ANM. LIMITATIONS, REASONS FOR CAUTION Strengths of the study include the large sample size and the broad set of potential confounders measured. However, results may have been underestimated due to survival bias. We cannot be sure about the sequence of the events in women with a late age at diabetes, as both events then occur in a short period. We could not distinguish between type 1 and type 2 diabetes. WIDER IMPLICATIONS OF THE FINDINGS Based on the literature, an accelerating effect of early-onset diabetes on ANM might be plausible. A delaying effect of late-onset diabetes on ANM has not been reported before, and is not in agreement with recent studies suggesting the opposite association. STUDY FUNDING/COMPETING INTERESTS The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ) and Federal Ministry of Education and Research (BMMF) (Germany); Ministry of Health and Social Solidarity, Stavros Niarchos Foundation and Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); ERC-2009-AdG 232997 and Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS), Regional Governments of Andalucía, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skåne and Västerbotten (Sweden); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, and Wellcome Trust (UK). None of the authors reported a conflict of interest.
Collapse
Affiliation(s)
- J S Brand
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - N C Onland-Moret
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - M J C Eijkemans
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - A Tjønneland
- Danish Cancer Society Research Center, Copenhagen, Denmark
| | - N Roswall
- Danish Cancer Society Research Center, Copenhagen, Denmark
| | - K Overvad
- Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark
| | - G Fagherazzi
- Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, F-94805 Villejuif, France
| | - F Clavel-Chapelon
- Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, F-94805 Villejuif, France
| | - L Dossus
- Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, F-94805 Villejuif, France
| | - A Lukanova
- Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany Department of Medical Biosciences, University of Umeå, Umeå, Sweden
| | - V Grote
- Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany
| | - M M Bergmann
- Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Potsdam, Germany
| | - H Boeing
- Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Potsdam, Germany
| | - A Trichopoulou
- WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, 75 M. Asias Street, Goudi GR-115 27, Athens, Greece Hellenic Health Foundation, 13 Kaisareias Street, Athens GR-115 27, Greece
| | - M Tzivoglou
- Hellenic Health Foundation, 13 Kaisareias Street, Athens GR-115 27, Greece
| | - D Trichopoulos
- Hellenic Health Foundation, 13 Kaisareias Street, Athens GR-115 27, Greece Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA Bureau of Epidemiologic Research, Academy of Athens, 28 Panepistimiou Street, Athens GR-106 79, Greece
| | - S Grioni
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - A Mattiello
- Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy
| | - G Masala
- Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy
| | - R Tumino
- Cancer Registry and Histopathology Unit, 'Civic - M.P. Arezzo' Hospital, ASP Ragusa, Italy
| | - P Vineis
- School of Public Health, Imperial College, London, UK HuGeF Foundation, Torino, Italy
| | - H B Bueno-de-Mesquita
- Dt. for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands Dt. of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands Dt. of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom Dt. of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - E Weiderpass
- Department of Community Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway Cancer Registry of Norway, Oslo, Norway Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Samfundet Folkhälsan, Helsinki, Finland
| | | | - M J Sánchez
- Andalusian School of Public Health, Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - J M Huerta Castaño
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain
| | - L Arriola
- Public Health Department of Gipuzkoa, Instituto BIO-Donostia, Basque Government, CIBERESP, San Sebastian, Spain
| | - E Ardanaz
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain Navarre Public Health Institute, Pamplona, Spain
| | - E J Duell
- Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain
| | - O Rolandsson
- Department of Public Health and Clinical Medicine, Family Medicine Umeå University, 901 87 Umeå, Sweden
| | - P W Franks
- Department of Clinical Sciences, Genetic & Molecular Epidemiology Unit, Clinical Research Center, Skåne University Hospital, Lund University, Malmö, Sweden Department of Medicine, Umeå University, Umeå, Sweden
| | - S Butt
- Department of Surgery, Institute of Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden
| | - P Nilsson
- Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmo, Sweden
| | - K T Khaw
- University of Cambridge, Cambridge, UK
| | - N Wareham
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - R Travis
- Cancer Epidemiology Unit, University of Oxford, Oxford, UK
| | - I Romieu
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - M J Gunter
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
| | - E Riboli
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
| | - Y T van der Schouw
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
16
|
Vismarra A, Mangia C, Passeri B, Brundu D, Masala G, Ledda S, Mariconti M, Brindani F, Kramer L, Bacci C. Immuno-histochemical study of ovine cystic echinococcosis (Echinococcus granulosus) shows predominant T cell infiltration in established cysts. Vet Parasitol 2015; 209:285-8. [DOI: 10.1016/j.vetpar.2015.02.027] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2014] [Revised: 02/20/2015] [Accepted: 02/23/2015] [Indexed: 01/30/2023]
|
17
|
Buijsse B, Boeing H, Drogan D, Schulze MB, Feskens EJ, Amiano P, Barricarte A, Clavel-Chapelon F, de Lauzon-Guillain B, Fagherazzi G, Fonseca-Nunes A, Franks PW, Huerta JM, Jakobsen MU, Kaaks R, Key TJ, Khaw KT, Masala G, Moskal A, Nilsson PM, Overvad K, Pala V, Panico S, Redondo ML, Ricceri F, Rolandsson O, Sánchez MJ, Sluijs I, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, Langenberg C, Sharp SJ, Forouhi NG, Riboli E, Wareham NJ. Consumption of fatty foods and incident type 2 diabetes in populations from eight European countries. Eur J Clin Nutr 2015; 69:455-61. [PMID: 25424603 DOI: 10.1038/ejcn.2014.249] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2014] [Revised: 09/08/2014] [Accepted: 09/19/2014] [Indexed: 12/25/2022]
Abstract
BACKGROUND/OBJECTIVES Diets high in saturated and trans fat and low in unsaturated fat may increase type 2 diabetes (T2D) risk, but studies on foods high in fat per unit weight are sparse. We assessed whether the intake of vegetable oil, butter, margarine, nuts and seeds and cakes and cookies is related to incident T2D. SUBJECTS/METHODS A case-cohort study was conducted, nested within eight countries of the European Prospective Investigation into Cancer (EPIC), with 12,403 incident T2D cases and a subcohort of 16,835 people, identified from a cohort of 340,234 people. Diet was assessed at baseline (1991-1999) by country-specific questionnaires. Country-specific hazard ratios (HRs) across four categories of fatty foods (nonconsumers and tertiles among consumers) were combined with random-effects meta-analysis. RESULTS After adjustment not including body mass index (BMI), nonconsumers of butter, nuts and seeds and cakes and cookies were at higher T2D risk compared with the middle tertile of consumption. Among consumers, cakes and cookies were inversely related to T2D (HRs across increasing tertiles 1.14, 1.00 and 0.92, respectively; P-trend <0.0001). All these associations attenuated upon adjustment for BMI, except the higher risk of nonconsumers of cakes and cookies (HR 1.57). Higher consumption of margarine became positively associated after BMI adjustment (HRs across increasing consumption tertiles: 0.93, 1.00 and 1.12; P-trend 0.03). Within consumers, vegetable oil, butter and nuts and seeds were unrelated to T2D. CONCLUSIONS Fatty foods were generally not associated with T2D, apart from weak positive association for margarine. The higher risk among nonconsumers of cakes and cookies needs further explanation.
Collapse
Affiliation(s)
- B Buijsse
- Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
| | - H Boeing
- Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
| | - D Drogan
- Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
| | - M B Schulze
- Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
| | - E J Feskens
- Division of Human Nutrition-Section Nutrition and Epidemiology, University of Wageningen, Wageningen, The Netherlands
| | - P Amiano
- 1] Public Health Division of Gipuzkoa, San Sebastian, Spain [2] Instituto BIO-Donostia, San Sebastian, Spain [3] Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain
| | - A Barricarte
- 1] Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain [2] Navarre Public Health Institute, Pamplona, Spain
| | - F Clavel-Chapelon
- 1] INSERM, Centre for Research in Epidemiology and Population Health, Villejuif, France [2] Paris South University, Villejuif, France
| | - B de Lauzon-Guillain
- 1] INSERM, Centre for Research in Epidemiology and Population Health, Villejuif, France [2] Paris South University, Villejuif, France
| | - G Fagherazzi
- 1] INSERM, Centre for Research in Epidemiology and Population Health, Villejuif, France [2] Paris South University, Villejuif, France
| | - A Fonseca-Nunes
- Unit Nutrition, Environment and Cancer, Department of Epidemiology, Catalan Institute of Oncology, Barcelona, Spain
| | - P W Franks
- 1] Department of Clinical Sciences, Clinical Research Center, Skåne University Hospital, Lund University, Malmö, Sweden [2] Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
| | - J M Huerta
- 1] Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain [2] Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain
| | - M U Jakobsen
- Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark
| | - R Kaaks
- Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany
| | - T J Key
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - K T Khaw
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
| | - G Masala
- Cancer Research and Prevention Institute, Florence, Italy
| | - A Moskal
- International Agency for Research on Cancer, Lyon, France
| | - P M Nilsson
- Department of Clinical Sciences, Clinical Research Center, Skåne University Hospital, Lund University, Malmö, Sweden
| | - K Overvad
- 1] Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark [2] Department of Cardiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
| | - V Pala
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - S Panico
- Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy
| | - M L Redondo
- Consejería de Sanidad, Public Health Directorate, Oviedo-Asturias, Spain
| | - F Ricceri
- Human Genetics Foundation, Turin, Italy
| | - O Rolandsson
- Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
| | - M-J Sánchez
- 1] Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain [2] Andalusian School of Public Health, Instituto de Investigación Biosanitaria (IBS GRANADA) and Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain
| | - I Sluijs
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - A M Spijkerman
- National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - A Tjonneland
- Danish Cancer Society Research Center, Copenhagen, Denmark
| | - R Tumino
- 1] Histopathology Unit, 'Civic MP Arezzo' Hospital, ASP Ragusa, Italy [2] Associazone Iblea per la Ricerca Epidemiologica-Onlus, Ragusa, Italy
| | - D L van der A
- National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - Y T van der Schouw
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - C Langenberg
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - S J Sharp
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - N G Forouhi
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| | - E Riboli
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK
| | - N J Wareham
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
| |
Collapse
|
18
|
Ose J, Fortner RT, Schock H, Peeters PH, Onland-Moret NC, Bueno-de-Mesquita HB, Weiderpass E, Gram IT, Overvad K, Tjonneland A, Dossus L, Fournier A, Baglietto L, Trichopoulou A, Benetou V, Trichopoulos D, Boeing H, Masala G, Krogh V, Matiello A, Tumino R, Popovic M, Obón-Santacana M, Larrañaga N, Ardanaz E, Sánchez MJ, Menéndez V, Chirlaque MD, Travis RC, Khaw KT, Brändstedt J, Idahl A, Lundin E, Rinaldi S, Kuhn E, Romieu I, Gunter MJ, Merritt MA, Riboli E, Kaaks R. Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort. Br J Cancer 2015; 112:162-6. [PMID: 25349976 PMCID: PMC4453611 DOI: 10.1038/bjc.2014.566] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2014] [Revised: 09/24/2014] [Accepted: 10/08/2014] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND Prospective studies on insulin-like growth factor I (IGF-I) and epithelial ovarian cancer (EOC) risk are inconclusive. Data suggest risk associations vary by tumour characteristics. METHODS We conducted a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC) to evaluate IGF-I concentrations and EOC risk by tumour characteristics (n=565 cases). Multivariable conditional logistic regression models were used to estimate associations. RESULTS We observed no association between IGF-I and EOC overall or by tumour characteristics. CONCLUSIONS In the largest prospective study to date was no association between IGF-I and EOC risk. Pre-diagnostic serum IGF-I concentrations may not influence EOC risk.
Collapse
Affiliation(s)
- J Ose
- Division of Cancer Epidemiology, German Cancer Research Center, 69120 Heidelberg, Germany
| | - R T Fortner
- Division of Cancer Epidemiology, German Cancer Research Center, 69120 Heidelberg, Germany
| | - H Schock
- Division of Cancer Epidemiology, German Cancer Research Center, 69120 Heidelberg, Germany
| | - P H Peeters
- Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 Utrecht, The Netherlands
| | - N C Onland-Moret
- Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 Utrecht, The Netherlands
| | - H B Bueno-de-Mesquita
- National Institute for Public Health and the Environment (RIVM), 3720 Bilthoven, The Netherlands
- Department of Gastroenterology and Hepatology, University Medical Centre, 3542 Utrecht, The Netherlands
- Department of Epidemiology and Statistics, the School of Public Health, Imperial College London, SW72AZ London, UK
| | - E Weiderpass
- Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, 90109 Tromsø, Norway
- Cancer Registry of Norway, 0304 Oslo, Norway
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden
- Department of Genetic Epidemiology, Folkhälsan Research Center, 00014 Helsinki, Finland
| | - I T Gram
- Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, 9037 Tromsø, Norway
| | - K Overvad
- Department of Public Health, Section for Epidemiology, Aarhus University, 8000 Aarhus, Denmark
| | - A Tjonneland
- Institute of Cancer Epidemiology, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark
| | - L Dossus
- Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, F-94805 Villejuif, France
- Univ Paris Sud, UMRS 1018, F-94805 Villejuif, France
- IGR, F-94805 Villejuif, France
| | - A Fournier
- Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, F-94805 Villejuif, France
- Univ Paris Sud, UMRS 1018, F-94805 Villejuif, France
- IGR, F-94805 Villejuif, France
| | - L Baglietto
- Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, 3004 Victoria, Australia
- Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, 3004 Victoria, Australia
| | - A Trichopoulou
- Bureau of Epidemiologic Research, Academy of Athens, 23 Alexandroupoleos Street, Athens GR-115 27, Greece
- Hellenic Health Foundation, 13 Kaisareias Street, Athens GR-115 27, Greece
| | - V Benetou
- Hellenic Health Foundation, 13 Kaisareias Street, Athens GR-115 27, Greece
- Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, 75M Asias Street, Goudi, Athens GR-115 27, Greece
| | - D Trichopoulos
- Bureau of Epidemiologic Research, Academy of Athens, 23 Alexandroupoleos Street, Athens GR-115 27, Greece
- Hellenic Health Foundation, 13 Kaisareias Street, Athens GR-115 27, Greece
- Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
| | - H Boeing
- Department of Epidemiology, German Institute of Human Nutrition (DIfE) 14558 Potsdam-Rehbrücke, Nuthetal, Germany
| | - G Masala
- Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute—ISPO, 50139 Florence, Italy
| | - V Krogh
- Epidemiology and Prevention Unit, Fondazione IRCCS Instituto Nazionale dei Tumori, Via Veneziani 1, 20133 Milano, Italy
| | - A Matiello
- Department of Clinical and Experimental Medicine, Federico II University, 80131 Naples, Italy
| | - R Tumino
- Cancer Registry and Histopathology Unit, ‘Civic - M.P. Arezzo' Hospita, ASP 97100 Ragusa, Italy
| | - M Popovic
- Unit of Cancer Epidemiology, AO Citta' della Salute e della Scienza, Department of Medical Sciences, University of Turin and Center for Cancer Prevention (CPO-Piemonte), 10126 Turin, Italy
| | - M Obón-Santacana
- Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), 08908 Barcelona, Spain
| | - N Larrañaga
- Public Health Division of Gipuzkoa-BIODonostia Research Institute, Basque Regional Health Department, 20013 San Sebastian, Spain
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER), 28029 Madrid, Spain
| | - E Ardanaz
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER), 28029 Madrid, Spain
- Navarre Public Health Institute, 31006 Pamplona, Spain
| | - M-J Sánchez
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER), 28029 Madrid, Spain
- Andalusian School of Public Health, 18011 Granada, Spain
| | - V Menéndez
- Public Health Directorate, 33006 Asturias, Spain
| | - M-D Chirlaque
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER), 28029 Madrid, Spain
- Department of Epidemiology, Murcia Regional Health Authority, 30008 Murcia, Spain
| | - R C Travis
- Cancer Epidemiology Unit, University of Oxford, OX30NR Oxford, UK
| | - K-T Khaw
- Department of Public Health and Primary Care, University of Cambridge, CB22QQ Cambridge, UK
| | - J Brändstedt
- Medical Department of Surgery, Malmö University Hospital, 20502 Malmö, Sweden
| | - A Idahl
- Department of Clinical Sciences, Obstetrics and Gynecology and Department of Public Health and Clinical Medicine, Nutritional Research Umeå University, 90185 Umeå, Sweden
| | - E Lundin
- Department of Medical Biosciences, Pathology Umeå University, 90185 Umeå, Sweden
| | - S Rinaldi
- International Agency for Research on Cancer, 69372 Lyon, France
| | - E Kuhn
- International Agency for Research on Cancer, 69372 Lyon, France
| | - I Romieu
- International Agency for Research on Cancer, 69372 Lyon, France
| | - M J Gunter
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, SW72AZ London, UK
| | - M A Merritt
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, SW72AZ London, UK
| | - E Riboli
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, SW72AZ London, UK
| | - R Kaaks
- Division of Cancer Epidemiology, German Cancer Research Center, 69120 Heidelberg, Germany
| |
Collapse
|
19
|
Sieri S, Krogh V, Agnoli C, Ricceri F, Palli D, Masala G, Panico S, Mattiello A, Tumino R, Giurdanella MC, Brighenti F, Scazzina F, Vineis P, Sacerdote C. Dietary glycemic index and glycemic load and risk of colorectal cancer: results from the EPIC-Italy study. Int J Cancer 2014; 136:2923-31. [PMID: 25403784 DOI: 10.1002/ijc.29341] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2014] [Accepted: 11/07/2014] [Indexed: 11/06/2022]
Abstract
A carbohydrate-rich diet, resulting in high blood glucose and insulin, has been hypothesized as involved in colorectal cancer etiology. We investigated dietary glycemic index (GI) and glycemic load (GL), in relation to colorectal cancer, in the prospectively recruited EPIC-Italy cohort. After a median 11.7 years, 421 colorectal cancers were diagnosed among 47,749 recruited adults. GI and GL were estimated from validated food frequency questionnaires. Multivariable Cox modeling estimated hazard ratios (HRs) for associations between colorectal cancer and intakes of total, high GI and low GI carbohydrate and GI and GL. The adjusted HR of colorectal cancer for highest versus lowest GI quartile was 1.35; 95% confidence interval (CI) 1.03-1.78; p trend 0.031. Increasing high GI carbohydrate intake was also significantly associated with increasing colorectal cancer risk (HR 1.45; 95% CI 1.04-2.03; p trend 0.034), whereas increasing low GI carbohydrate was associated with reducing risk (HR 0.73; 95% CI 0.54-0.98; p trend 0.033). High dietary GI and high GI carbohydrate were associated with increased risks of cancer at all colon sites (HR 1.37; 95% CI 1.00-1.88, HR 1.80; 95% CI 1.22-2.65, respectively), whereas high GI carbohydrate and high GL were associated with increased risk of proximal colon cancer (HR 1.94; 95% CI 1.18-3.16, HR 2.01; 95% CI 1.08-3.74, respectively). After stratification for waist-to-hip ratio (WHR), cancer was significantly associated with GI, and high GI carbohydrate, in those with high WHR. These findings suggest that high dietary GI and high carbohydrate intake from high GI foods are associated with increased risk of colorectal cancer.
Collapse
Affiliation(s)
- S Sieri
- Department of Preventive & Predictive Medicine, Epidemiology and Prevention Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Ottini L, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, Masala G, Navazio AS, Capalbo C, Bianchi S, Manoukian S, Barile M, Peterlongo P, Caligo MA, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Cini G, Montagna M, Radice P, Palli D. Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy. Breast Cancer Res Treat 2014; 148:623-8. [PMID: 25385181 DOI: 10.1007/s10549-014-3193-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2014] [Accepted: 10/31/2014] [Indexed: 12/31/2022]
Abstract
Male breast cancer (MBC) is rare and poorly understood. Like female breast cancer (FBC), MBCs are highly sensitive to hormonal changes, and hyperestrogenism, specifically, represents a major risk factor for MBC. MBC is considered similar to late-onset, post-menopausal estrogen/progesteron receptors positive FBC (ER+/PR+). Sulfotransferase 1A1 (SULT1A1) is an enzyme involved in the metabolism of estrogens. Recently, SULT1A1 common functional polymorphism Arg(213)His (638G>A) variant has been found to be associated with increased breast cancer (BC) risk, particularly in post-menopausal women. For this reason, we decided to explore whether SULT1A1 Arg(213)His could exert an effect on MBC development. The primary aim of this study was to evaluate the influence of the SULT1A1 Arg(213)His polymorphism on MBC risk. The secondary aim was to investigate possible associations with relevant clinical-pathologic features of MBC. A total of 394 MBC cases and 786 healthy male controls were genotyped for SULT1A1 Arg(213)His polymorphism by PCR-RFLP and high-resolution melting analysis. All MBC cases were characterized for relevant clinical-pathologic features. A significant difference in the distribution of SULT1A1 Arg(213)His genotypes was found between MBC cases and controls (P < 0.0001). The analysis of genotype-specific risk showed a significant increased MBC risk in individuals with G/A (OR 1.97, 95% CI 1.50-2.59; P < 0.0001) and A/A (OR 3.09, 95% CI 1.83-5.23; P < 0.0001) genotypes in comparison to wild-type genotype, under co-dominant model. A significant association between SULT1A1 risk genotypes and HER2 status emerged. Results indicate that SULT1A1 Arg(213)His may act as a low-penetrance risk allele for developing MBC and could be associated with a specific tumor subtype associated with HER2 overexpression.
Collapse
Affiliation(s)
- L Ottini
- Department of Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy,
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Stringhini S, Polidoro S, Sacerdote C, Kelly R, van VeldhovenK K, Agnoli C, Grioni S, TuminoR R, Giurdanella MC, Panico S, Mattiello A, Palli D, Masala G, Gallo V, Castagne R, PaccaudF F, Campanella G, Chadeau-Hyam M, Vineis P. Association of lifecourse socioeconomic status with DNA methylation of genes regulating inflammation. Eur J Public Health 2014. [DOI: 10.1093/eurpub/cku164.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Rinaldi S, Kaaks R, Friedenreich CM, Key TJ, Travis R, Biessy C, Slimani N, Overvad K, Østergaard JN, Tjønneland A, Olsen A, Mesrine S, Fournier A, Dossus L, Lukanova A, Johnson T, Boeing H, Vigl M, Trichopoulou A, Benetou V, Trichopoulos D, Masala G, Krogh V, Tumino R, Ricceri F, Panico S, Bueno-de-Mesquita HB, Monninkhof EM, May AM, Weiderpass E, Quirós JR, Travier N, Molina-Montes E, Amiano P, Huerta JM, Ardanaz E, Sund M, Johansson M, Khaw KT, Wareham N, Scalbert A, Gunter MJ, Riboli E, Romieu I. Physical activity, sex steroid, and growth factor concentrations in pre- and post-menopausal women: a cross-sectional study within the EPIC cohort. Cancer Causes Control 2014; 25:111-24. [PMID: 24173534 DOI: 10.1007/s10552-013-0314-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2013] [Accepted: 10/14/2013] [Indexed: 01/13/2023]
Abstract
PURPOSE Increased physical activity (PA) is associated with a reduced risk of several cancers. PA may reduce cancer risk by changing endogenous hormones levels, but relatively little research has focused on this topic. The purpose of this study was to elucidate the relation between PA and endogenous hormone concentrations. METHODS A cross-sectional analysis of 798 pre- and 1,360 post-menopausal women included as controls in case-control studies on endogenous hormones (steroids, progesterone, sex-hormone-binding globulin (SHBG), and growth factors) levels, and cancer risk nested within European Prospective Investigation into Cancer and Nutrition cohort was performed. Multivariate regression analyses were performed to compare geometric mean levels of hormones and SHBG by categories of PA. RESULTS In pre-menopausal women, active women had 19 % significantly lower concentrations of androstenedione, 14 % lower testosterone, and 20 % lower free testosterone than inactive women, while no differences were observed for estrogens, progesterone, SHBG, and growth factors. In post-menopausal women, active women had 18 % significantly lower estradiol and 20 % lower free estradiol concentrations than inactive women, while no differences were observed for the other hormones and SHBG. More vigorous forms of physical activity were associated with higher insulin-like growth factor-I concentrations. Adjustment for body mass index did not alter the associations. Overall, the percentage of variance in hormone concentrations explained by PA levels was <2 %. CONCLUSIONS Our results support the hypothesis of an influence, although small in magnitude, of PA on sex hormone levels in blood, independent of body size.
Collapse
Affiliation(s)
- S Rinaldi
- International Agency for Research on Cancer (IARC), Lyon, France,
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Sieri S, Pala V, Brighenti F, Agnoli C, Grioni S, Berrino F, Scazzina F, Palli D, Masala G, Vineis P, Sacerdote C, Tumino R, Giurdanella MC, Mattiello A, Panico S, Krogh V. High glycemic diet and breast cancer occurrence in the Italian EPIC cohort. Nutr Metab Cardiovasc Dis 2013; 23:628-634. [PMID: 22497978 DOI: 10.1016/j.numecd.2012.01.001] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2011] [Revised: 12/29/2011] [Accepted: 01/02/2012] [Indexed: 02/07/2023]
Abstract
BACKGROUND AND AIMS There are theoretical reasons for suspecting that a high glycemic index (GI) or glycemic load (GL) diet may increase breast cancer risk, perhaps via an effect on the insulin-like growth factor (IGF) axis. However observational studies have produced inconsistent findings and it is controversial whether breast cancer risk is influenced by the carbohydrate characteristics of the diet. We prospectively investigated the association between dietary GI and GL and breast cancer in the Italian section of the European Prospective Investigation into Cancer and Nutrition (EPIC). METHODS AND RESULTS Women were recruited from 1993 to 1998 at five centers: Varese and Turin (north Italy), Florence (central Italy), and Ragusa and Naples (south Italy). Participants completed validated food frequency questionnaires from which GI and GL were estimated. Multivariable Cox proportional hazard regression models quantified the association between breast cancer risk and total carbohydrate intake, GI, and GL. During 11 years of follow-up, 879 breast cancer (797 invasive and 82 in situ) cases were indentified. High dietary GL was associated with increased breast cancer risk (RR 1.45, 95% CI = 1.06-1.99; highest vs. lowest quintile; p-trend 0.029), whereas dietary GI and total carbohydrate had no influence. The association was not modified by menopausal status or body mass index. CONCLUSION Our data indicate that, in a Mediterranean population characterized by traditionally high and varied carbohydrate intake, a diet high in GL plays a role in the development of breast cancer.
Collapse
Affiliation(s)
- S Sieri
- Nutritional Epidemiology Unit, National Cancer Institute, Via Venezian 1, I-20133 Milan, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Zamora-Ros R, Knaze V, Romieu I, Scalbert A, Slimani N, Clavel-Chapelon F, Touillaud M, Perquier F, Skeie G, Engeset D, Weiderpass E, Johansson I, Landberg R, Bueno-de-Mesquita HB, Sieri S, Masala G, Peeters PHM, Grote V, Huerta JM, Barricarte A, Amiano P, Crowe FL, Molina-Montes E, Khaw KT, Argüelles MV, Tjønneland A, Halkjær J, de Magistris MS, Ricceri F, Tumino R, Wirfält E, Ericson U, Overvad K, Trichopoulou A, Dilis V, Vidalis P, Boeing H, Förster J, Riboli E, González CA. Impact of thearubigins on the estimation of total dietary flavonoids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Clin Nutr 2013; 67:779-82. [PMID: 23612513 DOI: 10.1038/ejcn.2013.89] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2012] [Revised: 03/18/2013] [Accepted: 03/29/2013] [Indexed: 11/09/2022]
Abstract
Thearubigins (TR) are polymeric flavanol-derived compounds formed during the fermentation of tea leaves. Comprising ∼70% of total polyphenols in black tea, TR may contribute majorly to its beneficial effects on health. To date, there is no appropriate food composition data on TR, although several studies have used data from the US Department of Agriculture (USDA) database to estimate TR intakes. We aimed to estimate dietary TR in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort and assess the impact of including TR or not in the calculation of the total dietary flavonoid intake. Dietary data were collected using a single standardized 24-h dietary recall interviewer-administered to 36 037 subjects aged 35-74 years. TR intakes were calculated using the USDA database. TR intakes ranged from 0.9 mg/day in men from Navarra and San Sebastian in Spain to 532.5 mg/day in men from UK general population. TR contributed <5% to the total flavonoid intake in Greece, Spain and Italy, whereas in the UK general population, TR comprised 48% of the total flavonoids. High heterogeneity in TR intake across the EPIC countries was observed. This study shows that total flavonoid intake may be greatly influenced by TR, particularly in high black tea-consuming countries. Further research on identification and quantification of TR is needed to get more accurate dietary TR estimations.
Collapse
Affiliation(s)
- R Zamora-Ros
- Catalan Institute of Oncology, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Ottini L, Silvestri V, Saieva C, Rizzolo P, Zanna I, Falchetti M, Masala G, Navazio AS, Graziano V, Bianchi S, Manoukian S, Barile M, Peterlongo P, D'Amico C, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D. Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy. Breast Cancer Res Treat 2013; 138:861-8. [PMID: 23468243 DOI: 10.1007/s10549-013-2459-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2013] [Accepted: 02/18/2013] [Indexed: 10/27/2022]
Abstract
It is well-known that male breast cancer (MBC) susceptibility is mainly due to high-penetrance BRCA1/2 mutations. Here, we investigated whether common low-penetrance breast cancer (BC) susceptibility alleles may influence MBC risk in Italian population and whether variant alleles may be associated with specific clinicopathological features of MBCs. In the frame of the Italian Multicenter Study on MBC, we genotyped 413 MBCs and 745 age-matched male controls at 9 SNPs annotating known BC susceptibility loci. By multivariate logistic regression models, we found a significant increased MBC risk for 3 SNPs, in particular, with codominant models, for rs2046210/ESR1 (OR = 1.71; 95 % CI: 1.43-2.05; p = 0.0001), rs3803662/TOX3 (OR = 1.59; 95 % CI: 1.32-1.92; p = 0.0001), and rs2981582/FGFR2 (OR = 1.26; 95 % CI: 1.05-1.50; p = 0.013). Furthermore, we showed that the prevalence of the risk genotypes of ESR1 tended to be higher in ER- tumors (p = 0.062). In a case-case multivariate analysis, a statistically significant association between ESR1 and ER- tumors was found (OR = 1.88; 95 % CI: 1.03-3.49; p = 0.039). Overall, our data, based on a large and well-characterized MBC series, support the hypothesis that common low-penetrance BC susceptibility alleles play a role in MBC susceptibility and, interestingly, indicate that ESR1 is associated with a distinct tumor subtype defined by ER-negative status.
Collapse
Affiliation(s)
- L Ottini
- Department of Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Bendinelli B, Palli D, Masala G, Sharp SJ, Schulze MB, Guevara M, van der ADL, Sera F, Amiano P, Balkau B, Barricarte A, Boeing H, Crowe FL, Dahm CC, Dalmeijer G, de Lauzon-Guillain B, Egeberg R, Fagherazzi G, Franks PW, Krogh V, Huerta JM, Jakszyn P, Khaw KT, Li K, Mattiello A, Nilsson PM, Overvad K, Ricceri F, Rolandsson O, Sánchez MJ, Slimani N, Sluijs I, Spijkerman AMW, Teucher B, Tjonneland A, Tumino R, van den Berg SW, Forouhi NG, Langeberg C, Feskens EJM, Riboli E, Wareham NJ. Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia 2013; 56:47-59. [PMID: 22983636 DOI: 10.1007/s00125-012-2718-7] [Citation(s) in RCA: 110] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2012] [Accepted: 07/24/2012] [Indexed: 01/12/2023]
Abstract
AIMS/HYPOTHESIS A diet rich in meat has been reported to contribute to the risk of type 2 diabetes. The present study aims to investigate the association between meat consumption and incident type 2 diabetes in the EPIC-InterAct study, a large prospective case-cohort study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) study. METHODS During 11.7 years of follow-up, 12,403 incident cases of type 2 diabetes were identified among 340,234 adults from eight European countries. A centre-stratified random subsample of 16,835 individuals was selected in order to perform a case-cohort design. Prentice-weighted Cox regression analyses were used to estimate HR and 95% CI for incident diabetes according to meat consumption. RESULTS Overall, multivariate analyses showed significant positive associations with incident type 2 diabetes for increasing consumption of total meat (50 g increments: HR 1.08; 95% CI 1.05, 1.12), red meat (HR 1.08; 95% CI 1.03, 1.13) and processed meat (HR 1.12; 95% CI 1.05, 1.19), and a borderline positive association with meat iron intake. Effect modifications by sex and class of BMI were observed. In men, the results of the overall analyses were confirmed. In women, the association with total and red meat persisted, although attenuated, while an association with poultry consumption also emerged (HR 1.20; 95% CI 1.07, 1.34). These associations were not evident among obese participants. CONCLUSIONS/INTERPRETATION This prospective study confirms a positive association between high consumption of total and red meat and incident type 2 diabetes in a large cohort of European adults.
Collapse
|
27
|
Cooper AJ, Forouhi NG, Ye Z, Buijsse B, Arriola L, Balkau B, Barricarte A, Beulens JWJ, Boeing H, Büchner FL, Dahm CC, de Lauzon-Guillain B, Fagherazzi G, Franks PW, Gonzalez C, Grioni S, Kaaks R, Key TJ, Masala G, Navarro C, Nilsson P, Overvad K, Panico S, Ramón Quirós J, Rolandsson O, Roswall N, Sacerdote C, Sánchez MJ, Slimani N, Sluijs I, Spijkerman AMW, Teucher B, Tjonneland A, Tumino R, Sharp SJ, Langenberg C, Feskens EJM, Riboli E, Wareham NJ. Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr 2012; 66:1082-92. [PMID: 22854878 PMCID: PMC3652306 DOI: 10.1038/ejcn.2012.85] [Citation(s) in RCA: 185] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2012] [Revised: 05/28/2012] [Accepted: 05/28/2012] [Indexed: 12/22/2022]
Abstract
Fruit and vegetable intake (FVI) may reduce the risk of type 2 diabetes (T2D), but the epidemiological evidence is inconclusive. The aim of this study is to examine the prospective association of FVI with T2D and conduct an updated meta-analysis. In the European Prospective Investigation into Cancer-InterAct (EPIC-InterAct) prospective case-cohort study nested within eight European countries, a representative sample of 16,154 participants and 12,403 incident cases of T2D were identified from 340,234 individuals with 3.99 million person-years of follow-up. For the meta-analysis we identified prospective studies on FVI and T2D risk by systematic searches of MEDLINE and EMBASE until April 2011. In EPIC-InterAct, estimated FVI by dietary questionnaires varied more than twofold between countries. In adjusted analyses the hazard ratio (95% confidence interval) comparing the highest with lowest quartile of reported intake was 0.90 (0.80-1.01) for FVI; 0.89 (0.76-1.04) for fruit and 0.94 (0.84-1.05) for vegetables. Among FV subtypes, only root vegetables were inversely associated with diabetes 0.87 (0.77-0.99). In meta-analysis using pooled data from five studies including EPIC-InterAct, comparing the highest with lowest category for FVI was associated with a lower relative risk of diabetes (0.93 (0.87-1.00)). Fruit or vegetables separately were not associated with diabetes. Among FV subtypes, only green leafy vegetable (GLV) intake (relative risk: 0.84 (0.74-0.94)) was inversely associated with diabetes. Subtypes of vegetables, such as root vegetables or GLVs may be beneficial for the prevention of diabetes, while total FVI may exert a weaker overall effect.
Collapse
Affiliation(s)
- A J Cooper
- MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Mastrandrea S, Stegel G, Piseddu T, Ledda S, Masala G. A retrospective study on burden of human echinococcosis based on Hospital Discharge Records from 2001 to 2009 in Sardinia, Italy. Acta Trop 2012; 123:184-9. [PMID: 22634205 DOI: 10.1016/j.actatropica.2012.05.004] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2011] [Revised: 05/07/2012] [Accepted: 05/13/2012] [Indexed: 11/29/2022]
Abstract
Cystic Echinococcosis (CE) is an infective zoonosis that represents a worldwide important public health problem. In humans, its manifestations may range from asymptomatic infection to severe disease and possible death, and lead to economic losses from treatment costs and lost wages. Recent studies suggest that this disease has a large social impact in endemic areas, and estimates of burden in terms of monetary and no-monetary impact on human health are essential to allocate financial and technical resources. In Sardinia, the most affected Italian region per number of inhabitants, CE is still endemic, although three eradication campaigns have been carried out in 1962, 1978, and 1987, respectively. To date, the burden of human CE in Sardinia remains poorly defined. In this work, a retrospective study was carried out using public Hospital Discharge Records spanning from 2001 to 2009. During these years, a total of 1409 discharges were recorded: 1196 (84.88%) records corresponding to patients hospitalized for symptoms directly correlated to CE (primary diagnosis), and 213 (15.11%) records corresponding to patients hospitalized for symptoms not directly correlated to CE and with an afterwards or concurrent diagnosis of echinococcosis made during the hospitalization (secondary diagnosis). The annual regional average record (discharge rate) was 9.3/100,000 inhabitants. Direct cost associated with diagnosis, surgery or chemotherapy, medical care, and hospitalization in humans were evaluated in this work. Furthermore, burden of disease was also evaluated by using the disability-adjusted life years (DALYs), the preferred disease-burden measure of the World Health Organization. Knowing the burden of human CE in Sardinia is extremely important to enable the prioritization of control measures for this preventable neglected disease. This is the first study describing the measure of the overall disease burden in an Italian region endemic for this disease, performed by calculating the number of CE patients from Hospital Discharge Records.
Collapse
Affiliation(s)
- S Mastrandrea
- Istituto Zooprofilattico Sperimentale della Sardegna - CeNRE, Sassari, Italy.
| | | | | | | | | |
Collapse
|
29
|
Zamora-Ros R, Knaze V, Luján-Barroso L, Kuhnle GGC, Mulligan AA, Touillaud M, Slimani N, Romieu I, Powell N, Tumino R, Peeters PHM, de Magistris MS, Ricceri F, Sonestedt E, Drake I, Hjartåker A, Skie G, Mouw T, Wark PA, Romaguera D, Bueno-de-Mesquita HB, Ros M, Molina E, Sieri S, Quirós JR, Huerta JM, Tjønneland A, Halkjær J, Masala G, Teucher B, Kaas R, Travis RC, Dilis V, Benetou V, Trichopoulou A, Amiano P, Ardanaz E, Boeing H, Förster J, Clavel-Chapelon F, Fagherazzi G, Perquier F, Johansson G, Johansson I, Cassidy A, Overvad K, González CA. Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr 2012; 66:932-41. [PMID: 22510793 DOI: 10.1038/ejcn.2012.36] [Citation(s) in RCA: 90] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2011] [Revised: 01/26/2012] [Accepted: 01/26/2012] [Indexed: 01/18/2023]
Abstract
BACKGROUND/OBJECTIVES Phytoestrogens are estradiol-like natural compounds found in plants that have been associated with protective effects against chronic diseases, including some cancers, cardiovascular diseases and osteoporosis. The purpose of this study was to estimate the dietary intake of phytoestrogens, identify their food sources and their association with lifestyle factors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. SUBJECTS/METHODS Single 24-hour dietary recalls were collected from 36,037 individuals from 10 European countries, aged 35-74 years using a standardized computerized interview programe (EPIC-Soft). An ad hoc food composition database on phytoestrogens (isoflavones, lignans, coumestans, enterolignans and equol) was compiled using data from available databases, in order to obtain and describe phytoestrogen intakes and their food sources across 27 redefined EPIC centres. RESULTS Mean total phytoestrogen intake was the highest in the UK health-conscious group (24.9 mg/day in men and 21.1 mg/day in women) whereas lowest in Greece (1.3 mg/day) in men and Spain-Granada (1.0 mg/day) in women. Northern European countries had higher intakes than southern countries. The main phytoestrogen contributors were isoflavones in both UK centres and lignans in the other EPIC cohorts. Age, body mass index, educational level, smoking status and physical activity were related to increased intakes of lignans, enterolignans and equol, but not to total phytoestrogen, isoflavone or coumestan intakes. In the UK cohorts, the major food sources of phytoestrogens were soy products. In the other EPIC cohorts the dietary sources were more distributed, among fruits, vegetables, soy products, cereal products, non-alcoholic and alcoholic beverages. CONCLUSIONS There was a high variability in the dietary intake of total and phytoestrogen subclasses and their food sources across European regions.
Collapse
Affiliation(s)
- R Zamora-Ros
- Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Rohrmann S, Steinbrecher A, Linseisen J, Hermann S, May A, Luan J, Ekelund U, Overvad K, Tjønneland A, Halkjær J, Fagherazzi G, Boutron-Ruault MC, Clavel-Chapelon F, Agnoli C, Tumino R, Masala G, Mattiello A, Ricceri F, Travier N, Amiano P, Ardanaz E, Chirlaque MD, Sanchez MJ, Rodríguez L, Nilsson LM, Johansson I, Hedblad B, Rosvall M, Lund E, Braaten T, Naska A, Orfanos P, Trichopoulou A, van den Berg S, Bueno-de-Mesquita HB, Bergmann MM, Steffen A, Kaaks R, Teucher B, Wareham NJ, Khaw KT, Crowe FL, Illner AK, Slimani N, Gallo V, Mouw T, Norat T, Peeters PHM. The association of education with long-term weight change in the EPIC-PANACEA cohort. Eur J Clin Nutr 2012; 66:957-63. [PMID: 22669330 DOI: 10.1038/ejcn.2012.55] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND/OBJECTIVES Cross-sectionally, educational attainment is strongly associated with the prevalence of obesity, but this association is less clear for weight change during adult life. The objective of this study is to examine the association between educational attainment and weight change during adult life in the European Prospective Investigation into Cancer and Nutrition (EPIC). SUBJECTS/METHODS EPIC is a cohort study with 361,467 participants and up to 10 years of follow-up. Educational attainment was categorized according to the highest obtained school level (primary school or less, vocational secondary training, other secondary education and university). Multivariate mixed-effects linear regression models were used to study education in relation to weight at age 20 years (self-reported), to annual change in weight between age 20 years and measured weight at recruitment, and to annual change in weight during follow-up time. RESULTS Higher educational attainment was associated with on average a lower body mass index (BMI) at age 20 years and a lower increase in weight up to recruitment (highest vs lowest educational attainment in men: -60 g per year (95% confidence interval (CI) -80; -40), women -110 g per year (95% CI -130; -80)). Although during follow-up after recruitment an increase in body weight was observed in all educational levels, gain was lowest in men and women with a university degree (high vs low education -120 g per year (95% CI -150; -90) and -70 g per year (95% CI -90; -60), respectively). CONCLUSIONS Existing differences in BMI between higher and lower educated individuals at early adulthood became more pronounced during lifetime, which possibly impacts on obesity-related chronic disease risk in persons with lower educational attainment.
Collapse
Affiliation(s)
- S Rohrmann
- Department of Cancer Epidemiology and Prevention, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Crowe FL, Key TJ, Appleby PN, Overvad K, Schmidt EB, Egeberg R, Tjønneland A, Kaaks R, Teucher B, Boeing H, Weikert C, Trichopoulou A, Ouranos V, Valanou E, Masala G, Sieri S, Panico S, Tumino R, Matullo G, Bueno-de-Mesquita HB, Boer JMA, Beulens JWJ, van der Schouw YT, Quirós JR, Buckland G, Sánchez MJ, Dorronsoro M, Huerta JM, Moreno-Iribas C, Hedblad B, Jansson JH, Wennberg P, Khaw KT, Wareham N, Ferrari P, Illner AK, Chuang SC, Norat T, Danesh J, Riboli E. Dietary fibre intake and ischaemic heart disease mortality: the European Prospective Investigation into Cancer and Nutrition-Heart study. Eur J Clin Nutr 2012; 66:950-6. [DOI: 10.1038/ejcn.2012.51] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
32
|
Milano G, Deriu L, Passino ES, Masala G, Saccomanno MF, Postacchini R, Fabbriciani C. The Effect of Autologous Conditioned Plasma on the Treatment of Focal Chondral Defects of the Knee. An Experimental Study. Int J Immunopathol Pharmacol 2011; 24:117-24. [DOI: 10.1177/03946320110241s222] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The purpose of the present study was to evaluate the effect of local application of Autologous Conditioned Plasma (ACP) on the treatment of full-thickness cartilage injuries of the knee. The hypothesis of the study was that ACP can enhance healing response of injured cartilage. A full-thickness chondral lesion on the weight-bearing area of the medial femoral condyle was performed in 30 sheep. Animals were divided into 2 groups, according to postoperative treatment: in group 1, weekly injections of ACP for five times were performed; in group 2, lesions were left untreated. Animals were sacrificed at 3, 6 and 12 months after treatment. A histological evaluation was performed according to a modified O'Driscoll histological score. Comparison between groups for each time interval was performed with the Student's t-test. Significance was set at P <0.05. A post-hoc power analysis was performed according to the hypothesis of the study. Histological evaluation at 3 and 6 months showed that group 1 had significantly greater total score than group 2. At 12 months, no significant difference was observed between groups. In conclusion, local injections of ACP for treatment of full-thickness cartilage injuries did not produce hyaline cartilage. However, it promoted reparative response of the cartilage defect until 6 months after treatment.
Collapse
Affiliation(s)
| | | | - E. Sanna Passino
- Department of Veterinary Surgery, University of Sassari, Sassari, Italy
| | - G. Masala
- Department of Veterinary Surgery, University of Sassari, Sassari, Italy
| | | | | | | |
Collapse
|
33
|
Capitta P, Zobba R, Masala G, Cocco R, Tola S, Parpaglia MLP. Isolation and Characterization of Bartonella Strains in Cats in Italy. Transbound Emerg Dis 2010; 57:201-4. [DOI: 10.1111/j.1865-1682.2010.01133.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Abstract
BACKGROUND An occupation-related susceptibility of orchestral wind instrument players to gastro-oesophageal reflux was hypothesized. AIM To compare reflux symptoms reported by wind instrument players with those reported by players of other instruments. METHODS A questionnaire was distributed to 1083 musicians (414 wind instrument players and 669 players of other instruments) from 21 Italian orchestras to obtain information on reflux symptoms in the year preceding the survey together with selected individual characteristics and lifestyle habits. Crude and adjusted prevalence rate ratios (PRR) were computed by a model including gender, age, body mass index, smoking status, alcohol consumption and other confounding factors. RESULTS Wind instrument players reported a higher prevalence of heartburn in the previous year than the other instrument players (adjusted PRR 1.23, CI 95% 1.04-1.46). Wind instrument players also reported higher, although not fully significant, prevalence of regurgitation (adjusted PRR 1.22, CI 95% 0.97-1.54). Flute and double-reed instrument players seem to carry a higher risk of reflux symptoms. CONCLUSIONS Wind instrument players reported a prevalence of typical reflux symptoms higher than other instrument players.
Collapse
Affiliation(s)
- G Cammarota
- Institute of Internal Medicine, Catholic University of Medicine and Surgery, Rome, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Zedda MT, Rolesu S, Pau S, Rosati I, Ledda S, Satta G, Patta C, Masala G. Epidemiological Study of Toxoplasma gondii Infection in Ovine Breeding. Zoonoses Public Health 2009; 57:e102-8. [DOI: 10.1111/j.1863-2378.2009.01292.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Mastrandrea S, Taras MS, Capitta P, Tola S, Marras V, Strusi G, Masala G. Detection of Bartonella henselae – DNA in macronodular hepatic lesions of an immunocompetent woman. Clin Microbiol Infect 2009; 15 Suppl 2:116-7. [DOI: 10.1111/j.1469-0691.2008.02190.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
Nagel G, Linseisen J, van Gils CH, Peeters PH, Boutron-Ruault MC, Clavel-Chapelon F, Romieu I, Tjønneland A, Olsen A, Roswall N, Witt PM, Overvad K, Rohrmann S, Kaaks R, Drogan D, Boeing H, Trichopoulou A, Stratigakou V, Zylis D, Engeset D, Lund E, Skeie G, Berrino F, Grioni S, Mattiello A, Masala G, Tumino R, Zanetti R, Ros MM, Bueno-de-Mesquita HB, Ardanaz E, Sánchez MJ, Huerta JM, Amiano P, Rodríguez L, Manjer J, Wirfält E, Lenner P, Hallmans G, Spencer EA, Key TJ, Bingham S, Khaw KT, Rinaldi S, Slimani N, Boffetta P, Gallo V, Norat T, Riboli E. Dietary β-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Res Treat 2009; 119:753-65. [DOI: 10.1007/s10549-009-0444-8] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2009] [Accepted: 06/10/2009] [Indexed: 01/10/2023]
|
38
|
Zobba R, Chessa G, Mastrandrea S, Pinna Parpaglia ML, Patta C, Masala G. Serological and molecular detection of Bartonella spp. in humans, cats and dogs from northern Sardinia, Italy. Clin Microbiol Infect 2009; 15 Suppl 2:134-5. [PMID: 19456814 DOI: 10.1111/j.1469-0691.2008.02203.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- R Zobba
- Dipartimento di Patologia e Clinica Veterinaria, Università degli Studi di Sassari, Sassari, Italy
| | | | | | | | | | | |
Collapse
|
39
|
Mum A, Masala G, Tola S, Satta G, Fois F, Pirns P, Rolain JM, Raoult D, Parola P. First direct detection of rickettsial pathogens and a new rickettsia, 'Candidatus Rickettsia barbariae', in ticks from Sardinia, Italy. Clin Microbiol Infect 2008; 14:1028-33. [DOI: 10.1111/j.1469-0691.2008.02082.x] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Falchetti M, Rizzolo P, Lupi R, Ceccarelli K, Masala G, Saieva C, Zanna I, Matullo G, Palli D, Ottini L. DNA repair and metabolic gene polymorphisms and male breast cancer risk. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)71550-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
41
|
Rizzolo P, Falchetti M, Lupi R, Ceccarelli K, Silvestri V, Masala G, Saieva C, Zanna I, Palli D, Ottini L. BRCA1/BRCA2 mutation profile and phenotypic features of male breast cancer: a population-based study in Italy. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)71337-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
42
|
Manunta ML, Careddu GM, Masala G, Columbano N, Doria C, Crissantu L, Sanna Passino E. Lumbar interbody expanding cage. A preliminary study on an animal model. Vet Comp Orthop Traumatol 2008; 21:382-384. [PMID: 18704248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Interbody fusion devices are used in human medicine for treating degenerative diseases of the spine. Currently, there is not a universally accepted assessment tool for determining fusion, and the definitive criteria for diagnosing a successful interbody fusion remain controversial. The aim of this study was to describe microscopic and helical computed tomography (CT) imaging in the assessment of lumbar interbody fusion using cylindrical threaded titanium expanding cage in sheep. One cylindrical threaded expanding titanium cage (Proconcept--SA, Orange, France) was inserted through a transperitoneal approach after radical discectomy and packed with cancellous bone autograft in five adult sheep. The subjects were euthanatized after three, six, 12, 18 and 24 months. CT images revealed lumbar fusion at 12 months post operation, whereas microscopic evaluations indicated the presence of lumbar fusion at 18 months. CT and histological grades were the same in 65% of the cases observed. There were not a significant difference between CT, histological and micro radiographic grades. Helical CT scanning can be considered to be a suitable method for the monitoring of lumbar fusion as it enables observation of the deposition of bony bridging within the cage.
Collapse
Affiliation(s)
- M L Manunta
- Department of Surgery, School of Veterinary Medicine, University of Sassari, Italy.
| | | | | | | | | | | | | |
Collapse
|
43
|
Sanna Passino E, Careddu GM, Manunta ML, Masala G, Columbano N, Muzzetto P, Muzzetto P. Cerebral cenurosis in sheep: an even present pathology. Vet Res Commun 2007; 31 Suppl 1:331-3. [PMID: 17682907 DOI: 10.1007/s11259-007-0106-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- E Sanna Passino
- Istituto di Patologia Generale, Anatomia Patologica e Clinica Ostetrico-Chirurgica Veterinari, Settore di Clinica Chirurgica Veterinaria, Università degli Studi di Sassari, Sassari, Italy.
| | | | | | | | | | | | | |
Collapse
|
44
|
Pinna Parpaglia ML, Masu G, Masala G, Porcu R, Zobba R, Pintori G, Cocco R. Seroprevalence of Bartonella henselae in Dogs and Cats in Sassari. Vet Res Commun 2007; 31 Suppl 1:317-20. [PMID: 17682904 DOI: 10.1007/s11259-007-0056-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- M L Pinna Parpaglia
- Institute of Special Pathology and Veterinary Clinical Medicine, Faculty of Veterinary Medicine, Sassari, Italy.
| | | | | | | | | | | | | |
Collapse
|
45
|
Magagna A, Plantinga Y, Salvini S, Ceroti M, Masala G, Ghiadoni L, Taddei S, Palli D, Salvetti A. Habitual Dietary Antioxidant Intake, Flow Mediated Dilation and Augmentation Index in Hypertensive Patients and Normotensive Controls. High Blood Press Cardiovasc Prev 2007. [DOI: 10.2165/00151642-200714030-00196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
|
46
|
Plantinga Y, Ghiadoni L, Magagna A, Salvini S, Ceroti M, Masala G, Palli D, Taddei S, Salvetti A. P.002 HABITUAL ANTIOXIDANT VITAMIN INTAKE, AUGMENTATION INDEX AND FLOW MEDIATED DILATION IN HYPERTENSIVE PATIENTS AND NORMOTENSIVE CONTROLS. Artery Res 2007. [DOI: 10.1016/j.artres.2007.07.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
47
|
Mastrandrea S, Mura MS, Tola S, Patta C, Tanda A, Porcu R, Masala G. Two Cases of Human Granulocytic Ehrlichiosis in Sardinia, Italy Confirmed by PCR. Ann N Y Acad Sci 2006; 1078:548-51. [PMID: 17114774 DOI: 10.1196/annals.1374.107] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In this work we report the first two cases of human granulocytic ehrlichiosis (HGE) in Sardinia. In early September 2004, a 69-year-old woman (patient 1) was admitted to the Infectious Diseases Institute of Sassari for rickettsiosis like-syndrome: high fever (39.5-40 degrees C), dyspnea, reduced consciousness, vomiting, and cutaneous rash. In late September 2004, a 30-year-old man (patient 2) with high fever was admitted for an evident palmar and oral erythema, edema of the labium, very intense arthralgia, myalgia, and dyspnea. In these two hospitalized patients, the diagnosis was made through indirect IgM and IgG immunofluorescent technique and confirmed by the presence of the specific DNA in the leukocytes. The two patients were A. phagocytophilum-PCR positive.
Collapse
Affiliation(s)
- S Mastrandrea
- Istituto Zooprofilattico Sperimentale della Sardegna, Via Duca degli Abruzzi 8, 07100 Sassari, Sardinia, Italy
| | | | | | | | | | | | | |
Collapse
|
48
|
Palli D, Saieva C, Luzzi I, Masala G, Topa S, Sera F, Gemma S, Zanna I, D'Errico M, Zini E, Guidotti S, Valeri A, Fabbrucci P, Moretti R, Testai E, del Giudice G, Ottini L, Matullo G, Dogliotti E, Gomez-Miguel MJ. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 2005; 100:1941-8. [PMID: 16128937 DOI: 10.1111/j.1572-0241.2005.50084.x] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
OBJECTIVES Host genetic factors, including the IL1 gene cluster, play a key role in determining the long-term outcome of Helicobacter pylori infection. The aim of the study was to investigate the relationship between selected IL1 loci polymorphisms and gastric cancer risk in an Italian population. METHODS In a case-control study we compared the IL1B-31 and IL1B+3954 biallelic and IL1RN pentaallelic variable number of tandem repeats (VNTR) polymorphisms in 185 gastric cancer patients and 546 controls randomly sampled from the general population of an area at high gastric cancer risk (Tuscany, Central Italy). RESULTS Genotype frequencies of the IL1B-31 T/C, IL1B+3954 C/T, and IL1RN polymorphisms among our population controls were in Hardy-Weinberg equilibrium. In multivariate analyses, no increase in gastric cancer risk was observed for the IL1B-31*C- and IL1B+3954*T- carriers; a significant 50% increase emerged for IL1RN*2 allele carriers (OR = 1.49; 95% CI: 1.01-2.21). Analyses based on combined genotypes showed also that the association with IL1RN*2 allele was limited to two-variant allele carriers who were also homozygous for the IL1B-31*T allele (OR = 2.23; 95% CI: 1.18-4.23) with a statistically significant interaction between these two genotypes (p= 0.043). Haplotype analysis showed an increased risk for the haplotype IL1RN*2/IL1B-31*T. CONCLUSIONS Our results suggest that host genetic factors (such as the IL1RN and the IL1B-31 polymorphisms) interact in the complex process of gastric carcinogenesis in this high-risk Italian population. Overall, this effect appears more modest than previously reported in other populations, supporting the hypothesis that other still-to-be-defined factors are important in gastric carcinogenesis. These findings might be due to a haplotype effect.
Collapse
Affiliation(s)
- D Palli
- Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Center (CSPO), Scientific Institute of Tuscany, Florence, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Abstract
Between 1999-2003, 14321 sera and 646 abortion samples (498 foetuses and 148 placentae) were analysed from 807 sheep and goat farms distributed all over the island of Sardinia. After notification of abortion in a flock, sera collected at random from adult animals were examined to detect antibodies specific to Chlamydophila (C.) abortus by ELISA, whereas foetuses and placenta were analysed by PCR assay. Specific IgG antibodies were detected in 611 (4.8%) sheep and 106 (5.8%) goats. From a total of 2050 ovine and 151 caprine fetal samples including muscle, liver, abomasum, spleen, brain and placenta, 29 (1.4%) ovine and 1 (0.6%) caprine samples were C. abortus PCR-positive. Placenta was the tissue with the highest detection rate. These results indicate that the seroprevalence of C. abortus infection in sheep and goats is very low in Sardinia, and PCR results demonstrate that C. abortus has no significant role in abortion, especially in goats.
Collapse
Affiliation(s)
- G Masala
- Istituto Zooprofilattico Sperimentale della Sardegna, Via Duca degli Abruzzi 8, 07100 Sassari, Italy.
| | | | | | | | | |
Collapse
|
50
|
Masala G, Bagnoli S, Ceroti M, Saieva C, Trallori G, Zanna I, D'Albasio G, Palli D. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut 2004; 53:1309-13. [PMID: 15306591 PMCID: PMC1774198 DOI: 10.1136/gut.2003.031476] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND AND AIMS Two divergent patterns of mortality for smoking related diseases in ulcerative colitis and Crohn's disease patients were suggested in a previous population based study in Florence, Italy. Long term follow up (median 15 years) was completed to re-evaluate mortality in this Mediterranean cohort. PATIENTS AND METHODS Overall, 920 patients with inflammatory bowel disease were followed until December 2001 or death, with seven patients (0.8%) lost to follow up. A total of 14 040 person years were available for analysis; 118 deaths were observed (81/689 in ulcerative colitis and 37/231 in Crohn's disease). Expected deaths were estimated using age, sex, and calendar specific national and local mortality rates; standardised mortality ratios (SMR) and 95% confidence interval (CI) were calculated. RESULTS Among Crohn's disease patients, mortality was strongly increased for gastrointestinal diseases (SMR 4.49 (95% CI 1.80-9.25)), all cancers (SMR 2.10 (95% CI 1.22-3.36)), and lung cancer (SMR 4.00 (95% CI 1.60-8.24)), leading to a significant 50% excess total mortality. Ulcerative colitis patients showed a significantly reduced total mortality because of lower cardiovascular (SMR 0.67 (95% CI 0.45-0.95)) and lung cancer (SMR 0.32 (95% CI 0.07-0.95)) mortality. No significant excess for colorectal cancer mortality was evident in this extended follow up. CONCLUSIONS These clearly divergent patterns of mortality correlate with documented differences in smoking habits between Crohn's disease and ulcerative colitis patients. Family doctors and gastroenterologists should consider stopping cigarette smoking a specific priority for Crohn's disease patients; the latter should be offered free participation in structured programmes for smoking cessation, with the aim of reducing smoking related excess mortality. Overall, no evidence of an increased mortality for large bowel cancer emerged in this series.
Collapse
Affiliation(s)
- G Masala
- Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany, Via di San Salvi 12, 50135 Florence, Italy
| | | | | | | | | | | | | | | |
Collapse
|